US20100163039A1 - Method for administering an inhalable compound - Google Patents

Method for administering an inhalable compound Download PDF

Info

Publication number
US20100163039A1
US20100163039A1 US12/455,666 US45566609A US2010163039A1 US 20100163039 A1 US20100163039 A1 US 20100163039A1 US 45566609 A US45566609 A US 45566609A US 2010163039 A1 US2010163039 A1 US 2010163039A1
Authority
US
United States
Prior art keywords
illustrates
instruction set
dispensing
receiving
dosing instruction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/455,666
Inventor
Roderick A. Hyde
Muriel Y. Ishikawa
Jordin T. Kare
Robert Langer
Eric C. Leuthardt
Elizabeth A. Sweeney
Clarence T. Tegreene
Lowell L. Wood, JR.
Victoria Y.H. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Searete LLC
Original Assignee
Searete LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/317,934 external-priority patent/US20100163024A1/en
Priority claimed from US12/319,143 external-priority patent/US20100163025A1/en
Priority claimed from US12/378,284 external-priority patent/US20100163033A1/en
Priority claimed from US12/378,485 external-priority patent/US8725529B2/en
Priority claimed from US12/380,013 external-priority patent/US20100166613A1/en
Priority claimed from US12/380,108 external-priority patent/US20100163034A1/en
Priority claimed from US12/380,587 external-priority patent/US20100163027A1/en
Priority claimed from US12/380,679 external-priority patent/US20100168525A1/en
Priority claimed from US12/383,509 external-priority patent/US8706518B2/en
Priority claimed from US12/383,819 external-priority patent/US20100168602A1/en
Priority claimed from US12/384,104 external-priority patent/US20100163036A1/en
Priority claimed from US12/384,203 external-priority patent/US8694330B2/en
Priority claimed from US12/386,574 external-priority patent/US20100168529A1/en
Priority claimed from US12/386,669 external-priority patent/US8738395B2/en
Priority claimed from US12/387,057 external-priority patent/US8712794B2/en
Priority claimed from US12/387,151 external-priority patent/US20100169259A1/en
Priority claimed from US12/387,321 external-priority patent/US20100163038A1/en
Priority claimed from US12/387,472 external-priority patent/US20100169260A1/en
Priority to US12/455,676 priority Critical patent/US20100163029A1/en
Application filed by Searete LLC filed Critical Searete LLC
Priority to US12/455,666 priority patent/US20100163039A1/en
Priority to US12/455,667 priority patent/US9750903B2/en
Priority to US12/455,681 priority patent/US20100163020A1/en
Priority to US12/455,672 priority patent/US9724483B2/en
Assigned to SEARETE LLC reassignment SEARETE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KARE, JORDIN T., WOOD, LOWELL L., JR., ISHIKAWA, MURIEL Y., SWEENEY, ELIZABETH A., WOOD, VICTORIA Y.H., TEGREENE, CLARENCE T., HYDE, RODERICK A., LANGER, ROBERT, LEUTHARDT, ERIC C.
Publication of US20100163039A1 publication Critical patent/US20100163039A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A61D7/04—Devices for anaesthetising animals by gases or vapours; Inhaling devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/588—Means for facilitating use, e.g. by people with impaired vision by olfactory feedback, i.e. smell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/08—Supports for equipment
    • A61M2209/088—Supports for equipment on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)

Definitions

  • the present application is related to and claims the benefit of the earliest available effective filing date(s) from the following listed application(s) (the “Related Applications”) (e.g., claims earliest available priority dates for other than provisional patent applications or claims benefits under 35 USC ⁇ 119(e) for provisional patent applications, for any and all parent, grandparent, great-grandparent, etc. applications of the Related Application(s)). All subject matter of the Related Applications and of any and all parent, grandparent, great-grandparent, etc. applications of the Related Applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.
  • a method includes, but is not limited to, dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • a method includes, but is not limited to, dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and receiving a dose of an inhalable compound for dispensing.
  • a method includes dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and receiving the inhalable compound.
  • a method includes dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and supporting a hands-free aerosol delivery system on the body of a mammal.
  • a method includes detecting a medical condition parameter of a mammal according to a medical condition parameter request; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and dispensing a dose of an inhalable compound according to a dosing instruction set.
  • FIG. 1A is a front elevation view illustrating a collar for dispensing one or more inhalable compounds.
  • FIG. 1B is a top plan view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1C is a partial cross-sectional side elevation view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1D is a partial cross-sectional side elevation view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1E is a schematic of a collar for dispensing one or more inhalable compounds.
  • FIG. 1F is a schematic of a compound for being dispensed by a collar for dispensing one or more inhalable compounds.
  • FIG. 1G is a schematic of a compound for being dispensed by a collar for dispensing one or more inhalable compounds.
  • FIG. 1H is a schematic of a collar for dispensing one or more inhalable compounds, where the collar is connected to various storage media.
  • FIG. 2 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 3 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 4 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 5 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 6 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 7 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 8 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 9 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 10 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 11 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 12 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 13 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 14 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 15 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 16 illustrates an alternative embodiment of the operational flow of FIG. 56 .
  • FIG. 17 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 18 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 19 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 20 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 21 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 22 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 23 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 24 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 25 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 26 illustrates an alternative embodiment of the operational flow of FIG. 57 .
  • FIG. 27 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 28 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 29 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 30 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 31 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 32 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 33 illustrates an alternative embodiment of the operational flow of FIG. 59 .
  • FIG. 34 illustrates an alternative embodiment of the operational flow of FIG. 60 .
  • FIG. 35 illustrates an alternative embodiment of the operational flow of FIG. 60 .
  • FIG. 36 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 37 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 38 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 39 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 40 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 41 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 42 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 43 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 44 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 45 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 46 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 47 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 48 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 49 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 50 illustrates an alternative embodiment of the operational flow of FIG. 49 .
  • FIG. 51 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 52 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 53 illustrates an alternative embodiment of the operational flow of FIG. 2 .
  • FIG. 54 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 55 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 56 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 57 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 58 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 59 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 60 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 61 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 62 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 63 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • FIG. 64 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • FIG. 65 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • FIG. 66 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • FIG. 67 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • FIG. 68 illustrates an alternative embodiment of the operational flow of FIG. 62 .
  • a hands-free article for dispensing one or more inhalable compounds is described in accordance with the present disclosure.
  • the hands-free article such as collar 100
  • the hands-free article may be worn by a subject 102 who can inhale a compound 104 dispensed by the collar 100 .
  • the subject 102 can generally include any biological entity having respiratory organs (e.g., lungs), such as a mammalian entity (e.g., a human, a dog, a lion, or another mammal), an avian entity (e.g., a bird of prey or another avian), an amphibian entity (e.g., a frog or another amphibian), a reptilian entity (e.g., an alligator, a crocodile, a tortoise, or another reptile), as well as other biological entities having respiratory organs.
  • a mammalian entity e.g., a human, a dog, a lion, or another mammal
  • an avian entity e.g., a bird of prey or another avian
  • an amphibian entity e.g., a frog or another amphibian
  • a reptilian entity e.g., an alligator, a
  • the collar 100 is maintained in an operable dispensing position.
  • the collar 100 may comprise a support for a hands-free aerosol delivery system on the body of a mammal.
  • the collar 100 may be disposed around a portion of the body of the subject 102 .
  • the collar 100 may encircle a neck portion 106 of the subject 102 .
  • the collar 100 may encircle a limb portion (e.g., wrist portion 108 ) of the subject 102 .
  • the collar 100 may encircle a torso portion (e.g., chest portion 110 ) of the subject 102 .
  • the collar 100 may encircle a head portion 112 of the subject 102 . It should be noted that the above-mentioned embodiments are provided by way of example and are not meant to be limiting of the present disclosure. Thus, it is contemplated that the collar 100 may be maintained in an operable dispensing position by attaching it to a variety of other portions of the body of the subject 102 .
  • the collar 100 may comprise a support member having a first end 114 and a second end 116 .
  • the first end 114 may be connected to the second end 116 , encircling and creating a closed loop (e.g., a circle) about the body part of the subject 102 .
  • the first end 114 may be connected to the second end 116 via a magnet 118 .
  • the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a hook 120 .
  • the first end 114 may be connected to the second end 116 via a snap connection 122 .
  • first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a threaded connection 124 .
  • first end 114 may be connected to the second end 116 via a belt-like connection 126 . It will be appreciated that this list of connections is provided by way of example and is not meant to be restrictive of the present disclosure. Other fastening devices may be utilized with the collar 100 .
  • the collar 100 includes a dispensing module 128 for dispensing some amount of material, such as a dose (e.g., measured quantity, prescribed quantity, therapeutic quantity, etc.) of a compound 104 (e.g., organic compound, pharmaceutical compound, therapeutic compound, homeopathic compound, nutraceutical compound, biological material, protein, nucleic acid, cell, peptide, etc.) for modulating, curing, diagnosing, mitigating, preventing, or treating one or more of a disease, disorder, symptom or a condition. Additionally, the compound 104 may be utilized for enhancing one or more of a physical well-being or a mental well-being.
  • the dispensing module 128 may be oriented in order to optimize delivery of the compound 104 to the subject 102 .
  • the dispensing module may be oriented to optimize respiratory receipt by the subject 102 . This may include orienting the dispensing module 128 such that an outlet (nozzle) 130 or jet emanating from the dispensing module 128 is pointed at (oriented towards) the nose 132 or mouth 134 of the subject 102 .
  • Some inhalable compounds for utilization with the collar 100 may include, but are not limited to inhalable insulin, an inhalable corticosteroid, an inhalable antibiotic, an inhalable beta-2 agonist, or an inhalable mast cell stabilizer. Further, compounds for utilization with the collar 100 may include a compound that acts locally or systemically. Compounds for utilization with the collar 100 may include a compound having a formulation such that the formulation includes a carrier, such as a gas carrier, a liquid carrier, or a solid carrier. Additionally, compounds for utilization with the collar 100 may include a compound having a formulation such that the formulation includes penetration or absorption enhancers. It should be noted that this list is provided by way of example only and is not meant to be restrictive of the present invention.
  • various mechanisms or compounds may be utilized to power (e.g., nebulize) the inhalable compound out of the collar 100 , such as O 2 (oxygen) or helium-O 2 (heliox).
  • Such compounds may be selected for improving the response of the subject (e.g., heliox when utilized with an inhaled bronchodilator such as an inhalable beta-2 agonist).
  • the dispensing module 128 may be maintained in an optimal position for optimizing delivery of the compound 104 to the subject 102 .
  • a relative position or direction to a desired respiratory target is determined.
  • a direction to the subject's nose 132 may be determined.
  • a position of the dispensing module 128 may then be maintained for optimizing delivery of the compound 104 .
  • the orientation of the outlet 130 may be maintained in the direction determined for the subject's nose 132 .
  • the position of the dispensing module 128 may be maintained via a weight 136 .
  • the position of the dispensing module may be maintained via an adhesive 138 .
  • the position of the dispensing module 128 may be maintained via a slide 140 . In an embodiment, the position of the dispensing module 128 may be maintained via a magnet 142 . In an embodiment, the position of the dispensing module 128 may be maintained via a fastener 144 (e.g., a button or a snap). In an embodiment, the position of the dispensing module 128 may be maintained via a spring 146 . It will be appreciated that this list is provided by way of example and is not meant to be restrictive of the present disclosure.
  • the delivery of the compound 104 can be controlled to optimize or regulate delivery of the material 104 to the subject 102 .
  • the delivery mechanism can be one or more of the same type of material delivery system (e.g., nebulizer), or may include at least two different delivery systems (e.g., nebulizer and a dry powder inhaler), the at least one outlet 130 may be one of a suite or an array of outlets (e.g., nozzles) 148 .
  • One or more outlets e.g., the first nozzle 130 and a second nozzle 150
  • the first and second nozzles 130 and 150 may be in different locations.
  • the direction of the subject's nose 132 may be determined.
  • a discharge direction for the dispensing module 128 can be controlled for optimizing delivery of the compound 104 .
  • the orientation of the dispensing module 128 can be controlled to orient the first outlet 130 and the second outlet 150 in the direction determined for the subject's nose 132 .
  • directed delivery of the compound 104 may be accomplished via a demand valve 152 coupled with programmable dosing.
  • directed delivery of the compound 104 may be accomplished via a charged particle dispersion.
  • the first outlet 130 , the second outlet 150 , or the suite of outlets 148 may include outlets having variable discharge characteristics, such as directional, volumetric, spray area, or other characteristics.
  • Various mechanical systems for delivering inhalable materials may include, but are not limited to, a vaporizer (e.g., a device for vaporizing liquid material for inhalation), a nebulizer (e.g., a device for administering material in the form of a mist for inhalation), a liquid aerosol system (e.g., a system for propelling fine droplets of material utilizing a gas), a dry powder inhalation system, an atomizer (e.g., a device for reducing a liquid material to a spray or vapor for inhalation), a metered dose inhaler (e.g., a device for releasing a metered dose of material for inhalation), a propellant-delivered system, a piezo-electric inhaler (e.g., an inhaler utilizing a piezo vibrator to deaggregate a material powder for subsequent inhalation by the subject), etc.
  • a vaporizer e.g., a device
  • the material 104 may be provided in removable or replaceable storage units.
  • the material 104 may be provided in an easily replaceable dose packet.
  • the material 104 may be provided in a removable canister. It will be appreciated that these storage units are provided by way of example, and other various storage configurations having varying shapes, sizes, and form factors may be utilized with the collar 100 .
  • FIG. 2 illustrates an operational flow 200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H , and/or with respect to other examples and contexts.
  • the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H .
  • the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • Operation 210 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set.
  • the collar 100 may include a memory 154 for storing a dosing instruction set.
  • the memory 154 may be connected to a processor 156 operatively configured for initiating the dispensing of a dose 158 of a compound 104 .
  • the processor 156 is connected to a pump 160 .
  • the processor 156 may electronically signal the pump 160 to dispense the dose 158 of the compound 104 .
  • operation 220 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • the collar 100 may be maintained in an operable position by positioning a weight 136 at one end of the collar 100 .
  • FIG. 3 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 3 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 302 , an operation 304 , an operation 306 , and/or an operation 308 .
  • the operation 302 illustrates dispensing a dose of an inhalable compound according to a defined dosing instruction set.
  • the memory 154 may store a defined dosing instruction set
  • a processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the dosing instruction set.
  • the operation 304 illustrates dispensing a dose of an inhalable compound according to a time defined dosing instruction set. For example, as shown in FIGS.
  • the memory 154 may store a time defined dosing instruction set, and the processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the time defined dosing instruction set.
  • the processor 156 is connected to a time keeping module 162 for determining when to dispense the compound 104 .
  • the compound 104 may be dispensed while the subject 102 is sleeping (or is scheduled to steep according to the time defined dosing instruction set).
  • the compound 104 may be dispensed shortly before the subject is scheduled to sleep (e.g., in the case of a compound including a sleep aid, or the like).
  • the operation 306 illustrates dispensing a dose of an inhalable compound according to a user defined dosing instruction set.
  • the memory 154 may store a user defined dosing instruction set
  • the processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the user defined dosing instruction set.
  • the collar 100 may include an interface 164 accessible by a user 166 for supplying the user defined dosing instruction set to the memory 154 (e.g., via the processor 156 ).
  • the operation 308 illustrates dispensing a dose of an inhalable compound according to a health care provider-defined dosing instruction set.
  • the collar 100 may include an interface 164 accessible by a physician 168 for supplying a physician defined dosing instruction set to the memory 154 (e.g., via the processor 156 ).
  • FIG. 4 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 4 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 402 , an operation 404 , an operation 406 , and/or an operation 408 . Further, the operation 402 illustrates dispensing a dose of an inhalable compound according to a need response dosing instruction set.
  • the collar 100 may include a memory 154 for storing a need response dosing instruction set.
  • the collar 100 may also include a transducer (e.g., a sensor module 170 ) for sensing a health or wellness-related characteristic (or another characteristic) of the subject 102 .
  • a transducer e.g., a sensor module 170
  • the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the characteristic corresponds to a need stored in the need response dosing instruction set.
  • a sensed characteristic includes a blood glucose level
  • the need response dosing instruction set includes instructions for dispensing a dose of the compound when the sensed blood glucose level is above a certain threshold.
  • the operation 404 illustrates dispensing a dose of an inhalable compound according to an environmental need response dosing instruction set.
  • the collar 100 may include a memory 154 for storing an environmental need response dosing instruction set.
  • the collar 100 may also include a sensor module 170 for sensing an environment occupied by the subject 102 . Based on the sensed environment of the subject 102 , the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the environment corresponds to an environment stored in the environmental need response dosing instruction set.
  • the sensed environment may include sensing an actual or likely trigger (e.g., an allergen, a chemical, an irritant, or a particulate).
  • a likely trigger may include, for example, a sensed environment where the presence of an animal increases a likelihood of dander, or an outside environment where a time of year (e.g., the month of May) increases a likelihood of pollen exposure.
  • a sensed environment includes an outdoor environment, and the environment need response dosing instruction set includes instructions for dispensing a dose of the compound when the outdoor environment is sensed.
  • the sensed environment includes at least one other individual (and possibly a number of other individuals, e.g., a crowd), and the environmental need response dosing instruction set includes instructions for dispensing a dose of a vaccine when the other individual is sensed.
  • the environmental need response dosing instruction set includes instructions for dispensing a dose of a calming agent or anti-anxiety medication when one or more other individuals are sensed.
  • the sensed environment does not include another individual
  • the environmental need response dosing instruction set includes instructions for dispensing a dose of a vaccine when the absence of other individuals is sensed.
  • the operation 406 illustrates dispensing a dose of an inhalable compound according to a location need response dosing instruction set.
  • the collar 100 may include a memory 154 for storing a location need response dosing instruction set.
  • the collar 100 may also include a sensor module 170 for sensing a location occupied by the subject 102 .
  • the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the location corresponds to a location stored in the location need response dosing instruction set.
  • a sensed location includes a school zone
  • the location need response dosing instruction set includes instructions for dispensing a dose of the compound when the school zone is sensed.
  • the sensed location includes a living space
  • the location need response dosing instruction set includes instructions for dispensing a dosage of a pheromone (or another substance) for preventing a pet from urinating in the living space.
  • the sensed location may include a litter box
  • the dosing instruction set may include instructions for dispensing a pheromone (or another substance) for enticing a pet to defecate in the litter box.
  • the operation 408 illustrates dispensing the inhalable compound in accordance with a dispensing order received by a dispensing module.
  • the dispensing module 128 may receive a dispensing order from the processor 156 .
  • the dispensing order may be dispatched upon the sensor module 170 detecting a condition of the subject, such as an asthmatic incident (e.g., a narrowing of the subject's airways).
  • a condition of the subject such as an asthmatic incident (e.g., a narrowing of the subject's airways).
  • the sensor module 170 may identify a symptom of an asthmatic incident, such as a subject experiencing trouble breathing, a sneeze, a cough, a wheeze, a rhonchus, or a snore.
  • the sensor module 170 may identify a physical condition associated with an asthmatic incident, such as a narrowing of the subject's airways.
  • Other symptoms or conditions detected by the sensor module 170 may include, but are not limited to, Chronic Obstructive Pulmonary Disease (COPD), bronchitis, abnormally high blood glucose level, etc. Further, it will be appreciated that the processor 156 may determine the most effective route of administration for a material based upon a particular condition or set of symptoms.
  • COPD Chronic Obstructive Pulmonary Disease
  • bronchitis abnormally high blood glucose level
  • the processor 156 may determine the most effective route of administration for a material based upon a particular condition or set of symptoms.
  • the processor 156 may determine that an inhalation route of delivery including the nasal cavity is a most effective route of treatment for an asthmatic incident, and may instruct administration of the dose 158 of the material 104 accordingly (e.g., in a case where the dose 158 includes a beta-2 agonist.)
  • the processor 156 may be programmed to determine whether a to-be-delivered agent should be provided to the subject via intra-nasal administration or inhalation, or both. For example, for a desired delivery of an agent to the brain of the subject, the device may be programmed to administer such agent through intranasal administration.
  • FIG. 5 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 5 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 502 , an operation 504 , and/or an operation 506 .
  • the operation 502 illustrates dispensing a dose of a nutraceutical compound.
  • the compound 104 may include a nutraceutical compound 172 .
  • the operation 504 illustrates dispensing a dose of a therapeutic compound.
  • the compound 104 may include a therapeutic compound 174 .
  • the operation 506 illustrates dispensing a dose of a homeopathic compound.
  • the compound 104 may include a homeopathic compound 176 .
  • FIG. 6 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 6 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 602 , an operation 604 , and/or an operation 606 .
  • the operation 602 illustrates generating an aerosol of the inhalable compound.
  • the compound 104 may include an aerosol which may be dispensed via the nozzle 130 .
  • the operation 604 illustrates generating at least one of a vapor or a powder of the inhalable compound.
  • the compound 104 may include a vapor which may be dispensed via the suite of nozzles 148 .
  • the compound 104 may include a powder, which may be dispensed via the suite of nozzles 148 .
  • Generating a powder may include, for example, generating particles, fine particles, micronized particles, microparticles, or particulates.
  • the operation 606 illustrates generating a liquid atomization of the inhalable compound.
  • the compound 104 may include an atomized liquid which may be dispensed via the nozzle 130 .
  • FIG. 7 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 7 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 702 , an operation 704 , an operation 706 , and/or an operation 708 .
  • the operation 702 illustrates administering the inhalable compound via spraying a compound.
  • the compound 104 may be sprayed via the nozzle 130 .
  • the operation 704 illustrates administering the inhalable compound via at least one of dusting or powderizing a compound.
  • the compound 104 may be dusted via the nozzle 130 .
  • Powderizing the compound may include, for example, de-agglomeration, or particularizing.
  • the operation 706 illustrates administering the inhalable compound via nebulizing a compound.
  • the compound 104 may be nebulized and dispensed via the nozzle 130 .
  • the operation 708 illustrates administering the inhalable compound via vaporizing a compound.
  • the compound 104 may be vaporized and dispensed via the nozzle 130 .
  • the inhalable compound may include a carrier.
  • a carrier may include a gas carrier, a liquid carrier, or a solid carrier.
  • the carrier may include a hydrocarbon, a fluorocarbon, a propellant, a salt, a saccharide, a lipid, a liposome, a synthetic, or a natural polymer.
  • various formulations including a carrier may include penetration or absorption enhancers.
  • FIG. 8 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 8 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 802 , an operation 804 , an operation 806 , and/or an operation 808 .
  • the operation 802 illustrates receiving a dose of a pharmaceutical compound for dispensing.
  • the compound 104 may include a pharmaceutical compound 178 .
  • the pharmaceutical compound 178 may be stored in a reservoir 180 of the collar 100 .
  • the reservoir 180 may receive one or more doses of the pharmaceutical compound 178 for dispensing.
  • the operation 804 illustrates receiving a dose of a therapeutic compound for dispensing.
  • the compound 104 may include a therapeutic compound 174 .
  • the therapeutic compound 174 may be stored in a reservoir 180 of the collar 100 .
  • the reservoir 180 may receive one or more doses of the therapeutic compound 174 for dispensing.
  • the operation 806 illustrates receiving a dosing instruction set.
  • the dosing instruction set may be received via the interface 164 .
  • the operation 808 illustrates receiving a dosing instruction set via a wireless transmission.
  • the dosing instruction set may be received via the interface 164 , which may include a wireless interface for receiving a wireless transmission.
  • FIG. 9 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 9 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 902 , and/or an operation 904 .
  • the operation 902 illustrates receiving a dosing instruction set via a processor.
  • the processor 156 may receive a dosing instruction set.
  • the operation 904 illustrates receiving a dosing instruction set via a connectable device containing digital instructions or data.
  • the collar 100 may receive a dosing instruction set from a connectable device 182 (e.g., a laptop computer, a personal digital assistant (PDA), or a cellular telephone).
  • a connectable device 182 e.g., a laptop computer, a personal digital assistant (PDA), or a cellular telephone.
  • PDA personal digital assistant
  • FIG. 10 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 10 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1002 , and/or an operation 1004 .
  • the operation 1002 illustrates receiving a dosing instruction set via a wire transmission.
  • the device 182 may be connected to the interface 164 via a wired connection.
  • the operation 1004 illustrates receiving a dosing instruction set via an optical transmission.
  • the device 182 may be connected to the interface 164 via an optical connection.
  • the device 182 may include an optical transmitter (e.g., a light), and the interface 164 may include an optical receiver (e.g., a light sensor).
  • FIG. 11 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 11 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1102 , and/or an operation 1104 .
  • the operation 1102 illustrates receiving a dosing instruction set via a radio transmission.
  • the device 182 may be connected to the interface 164 via a radio connection.
  • the device 182 may include a Radio Frequency (RF) transmitter, and the interface 164 may include an RF receiver.
  • the operation 1104 illustrates receiving a dosing instruction set via a mechanical transmission.
  • the device 182 may be connected to the interface 164 via a mechanical connection.
  • FIG. 12 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 12 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1202 , and/or an operation 1204 .
  • the operation 1202 illustrates receiving a dosing instruction set from a user.
  • the interface 164 may be utilized to receive a dosing instruction set from a user 166 .
  • the operation 1204 illustrates receiving a dosing instruction set from a health care provider.
  • a health care provider may include, for example, a physician, a physician's assistant, a nurse, a nurse practitioner, a pharmacist, or an emergency medical technician.
  • the interface 164 may be utilized to receive a dosing instruction set from a physician 168 .
  • FIG. 13 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 13 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1302 , and/or an operation 1304 .
  • the operation 1302 illustrates receiving a dosing instruction set from a pharmacist.
  • the interface 164 may be utilized to receive a dosing instruction set from a pharmacist 184 .
  • the operation 1304 illustrates receiving a dosing instruction set from at least one of a parent or a guardian.
  • the interface 164 may be utilized to receive a dosing instruction set from a parent 186 .
  • FIG. 14 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 14 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1402 , and/or an operation 1404 .
  • the operation 1402 illustrates receiving a dosing instruction set from at least one of a pet owner, an animal researcher, or an animal owner.
  • the interface 164 may be utilized to receive a dosing instruction set from a pet owner 188 .
  • the operation 1404 illustrates receiving a dosing instruction set from a veterinarian health care provider.
  • a veterinarian health care provider may include, among others, a veterinarian, a veterinarian's assistant, or a veterinarian technician.
  • the interface 164 may be utilized to receive a dosing instruction set from a veterinarian 190 .
  • the interface 164 may be utilized to receive a dosing instruction set from a researcher.
  • FIG. 15 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 15 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1502 .
  • the operation 1502 illustrates receiving a dosing instruction set from a medical response unit.
  • the interface 164 may be utilized to receive a dosing instruction set from a medical response unit 192 .
  • FIG. 16 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56 .
  • FIG. 16 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1602 , and/or an operation 1604 .
  • the operation 1602 illustrates receiving a dose of a homeopathic compound for dispensing.
  • the compound 104 may include one or more homeopathic compounds 176 .
  • the operation 1604 illustrates receiving a dose of a nutraceutical compound for dispensing.
  • the compound 104 may include one or more nutraceutical compounds 172 .
  • FIG. 17 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 17 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 1702 , an operation 1704 , and/or an operation 1706 .
  • the operation 1702 illustrates receiving the inhalable compound in a reservoir.
  • the compound 104 may be received in a reservoir 180 .
  • the operation 1704 illustrates monitoring a quantity of the inhalable compound in the reservoir.
  • the processor 156 may be utilized to monitor the compound 104 in the reservoir 180 .
  • the operation 1706 illustrates logging a quantity of the inhalable compound in the reservoir.
  • the processor 156 may be utilized to monitor the compound 104 in the reservoir 180
  • the memory 154 may be utilized to keep a log of a quantity of the compound 104 in the reservoir 180 .
  • the processor 156 may be utilized to monitor a time of dispensing the compound 104 from the reservoir 180 (e.g., by utilizing the time keeping module 162 ), and the memory 154 may be utilized to keep a log of a time of dispensing the compound 104 from the reservoir 180 .
  • FIG. 19 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 19 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 1902 , and/or an operation 1904 .
  • the operation 1902 illustrates logging a dispersion pattern of the inhalable compound dispensed from the reservoir.
  • the collar 100 may include a camera 194 for monitoring a dispersion pattern of the dispensed compound 104 , and the memory 154 may be utilized to log the dispersion pattern.
  • the operation 1904 illustrates logging a species of the inhalable compound dispensed from the reservoir.
  • the processor 156 may be utilized to determine a species of the compound 104 dispensed from the reservoir 180
  • the memory 154 may be utilized to log the determined species.
  • FIG. 20 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 20 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2002 . Further, the operation 2002 illustrates transmitting a set of logged reservoir information to an external location. For example, as shown in FIGS. 1A through 1H , the information logged by the memory 154 may be transmitted to an external location via the interface 164 .
  • FIG. 21 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 21 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2102 , and/or an operation 2104 .
  • the operation 2102 illustrates activating an alert when a quantity threshold of the inhalable compound in the reservoir is achieved.
  • the collar 100 may include a visual indicator 196 for issuing an alert when a quantity threshold of the compound 104 is achieved (e.g., as determined by the processor 156 ).
  • the operation 2104 illustrates activating a visual alert when a quantity threshold of the inhalable compound in the reservoir is achieved.
  • the visual indicator 196 may be activated when a quantity threshold of the compound 104 is achieved.
  • FIG. 22 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 22 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2202 .
  • the operation 2202 illustrates activating an auditory alert when a quantity threshold of the inhalable compound in the reservoir is achieved.
  • the collar 100 may include an audible indicator 198 for issuing an auditory alert when a quantity threshold of the compound 104 is achieved.
  • FIG. 23 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 23 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2302 .
  • the operation 2302 illustrates activating an electronic alert when a quantity threshold of the inhalable compound in the reservoir is achieved.
  • the collar 100 may include an electronic indicator 50 for issuing an electronic alert when a quantity threshold of the compound 104 is achieved.
  • FIG. 24 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 24 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2402 , an operation 2404 , and/or an operation 2406 .
  • the operation 2402 illustrates receiving the inhalable compound in a reloadable reservoir.
  • the reservoir 180 may include one or more reloadable reservoirs.
  • the operation 2404 illustrates receiving the inhalable compound in at least one of a disposable reservoir or a multi-component reservoir.
  • the reservoir 180 may include one or more disposable reservoirs.
  • the operation 2406 illustrates receiving the inhalable compound in a multi-compound reservoir.
  • the reservoir 180 may include one or more compounds, such as a first compound 104 and a second compound.
  • FIG. 25 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 25 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2502 , an operation 2504 , and/or an operation 2506 .
  • the operation 2502 illustrates receiving the inhalable compound in a single compound reservoir.
  • the reservoir 180 may include a single compound, such as the first compound 104 .
  • the operation 2504 illustrates receiving the inhalable compound in a dispensing reservoir.
  • the compound 104 received in the reservoir 180 may be an inhalable compound.
  • the operation 2506 illustrates receiving the inhalable compound in a modular reservoir.
  • the reservoir 180 may include a module reservoir.
  • FIG. 26 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57 .
  • FIG. 26 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2602 , and/or an operation 2604 .
  • the operation 2602 illustrates receiving the inhalable compound in a programmable reservoir.
  • the reservoir 180 may include a programmable reservoir, which may be programmable via the processor 156 .
  • the operation 2604 illustrates receiving the inhalable compound in a weighted reservoir.
  • the reservoir 180 may include a weighted reservoir, which may be weighted with a weight 136 .
  • FIG. 27 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 27 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2702 , an operation 2704 , and/or an operation 2706 .
  • the operation 2702 illustrates disposing the hands-free aerosol delivery system substantially around a portion of the body of a mammal.
  • the collar 100 may encircle the neck portion 106 of a subject 102 .
  • the operation 2704 illustrates encircling a neck portion of the body of a mammal with a support member of the hands-free aerosol delivery device.
  • the collar 100 may encircle the neck portion 106 of a subject 102 .
  • the operation 2706 illustrates encircling a wrist portion of the body of a mammal with a support member of the hands-free aerosol delivery device.
  • the collar 100 may encircle the wrist portion 108 of a subject 102 .
  • FIG. 28 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 28 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2802 , and/or an operation 2804 .
  • the operation 2802 illustrates encircling a chest portion of the body of a mammal with a support member of the hands-free aerosol delivery device.
  • the collar 100 may encircle a chest portion 110 of the subject 102 .
  • the operation 2804 illustrates encircling a head portion of the body of a mammal with a support member of the hands-free aerosol delivery device.
  • the collar 100 may encircle a head portion 112 of the subject 102 .
  • FIG. 29 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 29 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2902 , and/or an operation 2904 .
  • the operation 2902 illustrates connecting a first end of a support member of a hands-free aerosol delivery device to a second end of a support member of a hands-free aerosol delivery device while creating a circle about the body part of a mammal.
  • the collar 100 may comprise a support member having a first end 114 and a second end 116 .
  • the first end 114 may be connected to the second end 116 , encircling and creating a closed loop (e.g., a circle) about the body part of the subject 102 .
  • the operation 2904 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a magnet.
  • the first end 114 may be connected to the second end 116 via a magnet 118 .
  • FIG. 30 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 30 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3002 .
  • the operation 3002 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a hook.
  • the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a hook 120 .
  • FIG. 31 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 31 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3102 .
  • the operation 3102 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a snap connection.
  • the first end 114 may be connected to the second end 116 via a snap connection 122 .
  • FIG. 32 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 32 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3202 .
  • the operation 3202 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a threaded connection.
  • the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a threaded connection 124 .
  • FIG. 33 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59 .
  • FIG. 33 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3302 .
  • the operation 3302 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a belt-like connection.
  • the first end 114 may be connected to the second end 116 via a belt-like connection 126 .
  • FIG. 34 illustrates alternative embodiments of the example operational flow 6000 of FIG. 60 .
  • FIG. 34 illustrates example embodiments where the operation 6010 may include at least one additional operation. Additional operations may include an operation 3402 , an operation 3404 , and/or an operation 3406 .
  • the operation 3402 illustrates detecting a blood glucose level in the mammal.
  • the sensor module 170 may be utilized to detect a blood glucose level in the subject 102 .
  • the operation 3404 illustrates detecting a blood oxygen level in the mammal.
  • the sensor module 170 may be utilized to detect a blood oxygen level in the subject 102 .
  • the operation 3406 illustrates detecting an infection in the mammal.
  • the sensor module 170 may be utilized to detect an infection in the subject 102 .
  • FIG. 35 illustrates alternative embodiments of the example operational flow 6000 of FIG. 60 .
  • FIG. 35 illustrates example embodiments where the operation 6010 may include at least one additional operation. Additional operations may include an operation 3502 , an operation 3504 , and/or an operation 3506 .
  • the operation 3502 illustrates detecting vascular dysfunction in the mammal.
  • the sensor module 170 may be utilized to detect a vascular dysfunction in the subject 102 .
  • the operation 3504 illustrates detecting blood flow in the mammal.
  • the sensor module 170 may be utilized to detect blood flow in the subject 102 .
  • the operation 3506 illustrates detecting respiratory minute volume in the mammal.
  • the sensor module 170 may be utilized to detect a respiratory volume in the subject 102 .
  • the sensor module 170 may be utilized to detect a sneeze of the subject 102 .
  • the sensor module 170 may be utilized to detect a cough of the subject 102 .
  • the sensor module 170 may be utilized to detect a wheeze of the subject 102 .
  • the sensor module 170 may be utilized to detect a rhonchus of the subject 102 .
  • the sensor module 170 may be utilized to detect a snore of the subject 102 .
  • the sensor module 170 may be utilized to detect a temperature (e.g., a body temperature) of the subject 102 . In an embodiment, the sensor module 170 may be utilized to detect an expelled gas from the subject 102 , such as a gas exhaled by the subject.
  • a temperature e.g., a body temperature
  • the sensor module 170 may be utilized to detect an expelled gas from the subject 102 , such as a gas exhaled by the subject.
  • FIG. 36 illustrates an operational flow 3600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 36 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 3610 .
  • Operation 3610 illustrates dispensing a dose of a pharmaceutical compound.
  • the collar 100 may be utilized to dispense a dose 158 of a pharmaceutical compound 178 to the subject 102 .
  • FIG. 37 illustrates an operational flow 3700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 37 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 3710 .
  • Operation 3710 illustrates directing issuance of a dispensing order.
  • the processor 156 may direct issuance of a dispensing order (e.g., to the pump 160 ).
  • FIG. 38 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 38 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 3802 , an operation 3804 , and/or an operation 3806 .
  • the operation 3802 illustrates accepting a dosing instruction set from a user.
  • the interface 164 may be utilized to receive a dosing instruction set from a user 166 .
  • the operation 3804 illustrates accepting a dosing instruction set from at least one of a physician, a health care provider, a physician's assistant, a nurse, a nurse practitioner, a registered nurse, a licensed practical nurse, a pharmacist, or an emergency responder.
  • the interface 164 may be utilized to receive a dosing instruction set from a physician 168 .
  • the operation 3806 illustrates accepting a dosing instruction set from a medical response unit.
  • the interface 164 may be utilized to receive a dosing instruction set from a medical response unit 192 .
  • FIG. 39 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 39 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 3902 , an operation 3904 , and/or an operation 3906 .
  • the operation 3902 illustrates validating a dosing instruction set for performing a function.
  • the processor 156 may be utilized to validate a dosing instruction set (e.g., by check the dosing instruction set against information stored in the memory 154 ).
  • the operation 3904 illustrates translating a dosing instruction set for performing a function into a dispensing order. For example, as shown in FIGS.
  • the processor 156 may be utilized to translate a dosing instruction set into a dispensing order (e.g., by referencing the dosing instruction set to a lookup table stored in the memory 154 ). Further, the operation 3906 illustrates translating a medical parameter into a dispensing order. For example, as shown in FIGS. 1A through 1H , the processor 156 may be utilized to translate a medical parameter into a dispensing order (e.g., by referencing the medical parameter to a lookup table stored in the memory 154 ).
  • FIG. 40 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 40 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 4002 , an operation 4004 , and/or an operation 4006 .
  • the operation 4002 illustrates generating a dispensing order according to the instruction set from a user.
  • the processor 156 may be utilized to generate a dispensing order according to an instruction set from a user 166 stored in the memory 154 .
  • the operation 4004 illustrates generating a dispensing order according to the instruction set from a health care professional. For example, as shown in FIGS.
  • the processor 156 may be utilized to generate a dispensing order according to an instruction set from a physician 168 stored in the memory 154 .
  • the operation 4006 illustrates generating a dispensing order according to the instruction set from a medical response unit.
  • the processor 156 may be utilized to generate a dispensing order according to an instruction set from a medical response unit 192 stored in the memory 154 .
  • FIG. 41 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 41 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 4102 .
  • the operation 4102 illustrates requesting a dose of the inhalable compound in accordance with a dispensing order received by a dispensing module from a reservoir.
  • the dispensing module 128 may receive a request from the reservoir 180 for a dose of the compound 104 .
  • FIG. 42 illustrates an operational flow 4200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 42 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4210 .
  • Operation 4210 illustrates transmitting a dispensing order to a dispensing module.
  • the processor 156 may transmit a dispensing order to the dispensing module 128 (e.g., to the reservoir 180 ).
  • FIG. 43 illustrates an operational flow 4300 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 43 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4310 .
  • Operation 4310 illustrates transmitting a dispensing order to a dispensing module via a wireless transmission.
  • the dispensing module 128 may receive a dispensing order from a physician 168 via a wireless transmission received by the interface 164 .
  • FIG. 44 illustrates an operational flow 4400 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 44 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4410 .
  • Operation 4410 illustrates transmitting a dispensing order to a dispensing module via an optical transmission.
  • the dispensing module 128 may receive a dispensing order from a physician 168 via an optical transmission received by the interface 164 .
  • FIG. 45 illustrates an operational flow 4500 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 45 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4510 .
  • Operation 4510 illustrates transmitting a dispensing order to a dispensing module via a wire transmission.
  • the dispensing module 128 may receive a dispensing order from a physician 168 via an wire transmission received by the interface 164 .
  • FIG. 46 illustrates an operational flow 4600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 46 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4610 .
  • Operation 4610 illustrates transmitting a dispensing order to a dispensing module via a mechanical transmission.
  • the dispensing module 128 may receive a dispensing order from a physician 168 via a mechanical transmission received by the interface 164 .
  • FIG. 47 illustrates an operational flow 4700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 47 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4710 .
  • Operation 4710 illustrates transmitting a dispensing order to a dispensing module via a radio transmission.
  • the dispensing module 128 may receive a dispensing order from a physician 168 via a radio transmission received by the interface 164 .
  • FIG. 48 illustrates an operational flow 4800 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 48 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4810 .
  • Operation 4810 illustrates transmitting a dispensing order to a dispensing module via a processor transmission.
  • the dispensing module 128 may receive a dispensing order from the processor 156 .
  • FIG. 49 illustrates an operational flow 4900 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 49 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4910 , an operation 4912 , an operation 4914 , and/or an operation 4916 .
  • Operation 4910 illustrates controlling delivery of an inhalable compound.
  • the demand valve 152 may be utilized to control delivery of the compound 104 .
  • the operation 4912 illustrates selecting one or more delivery nozzles from a suite of nozzles.
  • the second nozzle 150 may be selected from the suite of nozzles 148 .
  • the operation 4914 illustrates directing delivery of the inhalable compound from one or more nozzles at different locations.
  • the compound 104 may be delivered from the first nozzle 130 or the second nozzle 150 .
  • the operation 4916 illustrates directing delivery of the inhalable compound by controlling a discharge direction.
  • a discharge direction for the dispensing module 128 may be controlled for optimizing delivery of the compound 104 .
  • FIG. 50 illustrates alternative embodiments of the example operational flow 4900 of FIG. 49 .
  • FIG. 50 illustrates example embodiments where the operation 4910 may include at least one additional operation. Additional operations may include an operation 5002 , an operation 5004 , and/or an operation 5006 .
  • the operation 5002 illustrates directing delivery via a demand valve coupled with programmable dosing.
  • the demand valve 152 may be operatively configured to dispense the compound 104 in accordance with a dosing schedule stored in the memory 154 .
  • the operation 5004 illustrates directing delivery via a charged particle dispersion.
  • the dispensing module 128 may dispense the compound 104 as a charged particle dispersion.
  • the operation 5006 illustrates directing delivery via a nozzle comprising variable discharge characteristics.
  • the first nozzle 130 , the second nozzle 150 , or the suite of nozzles 148 may include nozzles having variable discharge characteristics, such as directional, volumetric, spray area, or other characteristics.
  • FIG. 51 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 51 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5102 , an operation 5104 , and/or an operation 5106 .
  • the operation 5102 illustrates orienting a dispensing module to optimize respiratory receipt of an inhalable compound.
  • the dispensing module 128 may be maintained in an optimal position for optimizing delivery of the compound 104 to the subject 102 .
  • the operation 5104 illustrates maintaining a dispensing module in position to optimize respiratory receipt of an inhalable compound.
  • the orientation of the nozzle 130 may be maintained in the direction determined for the subject's nose 132 .
  • the operation 5106 illustrates determining a relative position or direction to a desired respiratory target. For example, as shown in FIGS. 1A through 1H , the direction to the subject's nose 132 may be calculated.
  • FIG. 52 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 52 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5202 , an operation 5204 , and/or an operation 5206 .
  • the operation 5202 illustrates maintaining a position of the dispensing module via a weight.
  • the position of the dispensing module 128 may be maintained via a weight 136 .
  • the operation 5204 illustrates maintaining a position of the dispensing module via an adhesive.
  • the position of the dispensing module may be maintained via an adhesive 138 .
  • the operation 5206 illustrates maintaining a position of the dispensing module via a slide.
  • the position of the dispensing module 128 may be maintained via a slide 140 .
  • FIG. 53 illustrates alternative embodiments of the example operational flow 200 of FIG. 2 .
  • FIG. 53 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5302 , an operation 5304 , and/or an operation 5306 .
  • the operation 5302 illustrates maintaining a position of the dispensing module via a magnet.
  • the position of the dispensing module 128 may be maintained via a magnet 142 .
  • the operation 5304 illustrates maintaining a position of the dispensing module via a fastener.
  • a fastener 144 e.g., a button or a snap.
  • the operation 5306 illustrates maintaining a position of the dispensing module via a spring.
  • the position of the dispensing module 128 may be maintained via a spring 146 .
  • FIG. 54 illustrates an operational flow 5400 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 54 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 5410 , an operation 5412 , an operation 5414 , and/or an operation 5416 .
  • Operation 5410 illustrates dispensing a tracer compound in association with the inhalable compound.
  • the compound 104 may comprise an inhalable compound 52 and one or more tracer compounds.
  • the operation 5412 illustrates dispensing a visual tracer compound.
  • the compound 104 may include a visual tracer 54 .
  • the operation 5414 illustrates dispensing an olfactory tracer compound.
  • the compound 104 may include an olfactory tracer 56 .
  • the operation 5416 illustrates dispensing a tastable tracer compound.
  • the compound 104 may include a tastable tracer 58 .
  • FIG. 55 illustrates an operational flow 5500 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 55 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 5510 , an operation 5512 , an operation 5514 , an operation 5516 , and/or an operation 5518 .
  • Operation 5510 illustrates providing an externally observable indication of dispensing of the inhalable compound.
  • the collar 100 may include a visual indicator 196 for indicating dispensing of the inhalable compound.
  • the operation 5512 illustrates providing a visual indication of dispensing of the inhalable compound.
  • the collar 100 may include the visual indicator 196 for indicating dispensing of the inhalable compound.
  • the operation 5514 illustrates providing a auditory indication of dispensing of the inhalable compound.
  • the collar 100 may include an audible indicator 198 .
  • the operation 5516 illustrates providing a vibrational indication of dispensing of the inhalable compound.
  • the collar 100 may include a vibrational indicator 60 .
  • the operation 5518 illustrates providing an electromagnetic indication of dispensing of the inhalable compound.
  • the collar 100 may include an electromagnetic indicator 62 .
  • FIG. 56 illustrates an operational flow 5600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H , and/or with respect to other examples and contexts.
  • the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H .
  • the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • Operation 5610 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set.
  • the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154 .
  • operation 5620 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • the collar 100 may be maintained in an operable dispensing position with an adhesive 138 .
  • operation 5630 depicts receiving the dose of the inhalable compound for dispensing.
  • the compound 104 may be received via the reservoir 180 .
  • FIG. 57 illustrates an operational flow 5700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 57 and in following figures that include various examples of operational flows discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H , and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H .
  • the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • Operation 5710 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set.
  • the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154 .
  • operation 5720 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • the collar 100 may be maintained in an operable dispensing position with an adhesive 138 .
  • operation 5730 depicts receiving the inhalable compound.
  • the compound 104 may be received via the reservoir 180 .
  • FIG. 58 illustrates an operational flow 5800 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 58 illustrates an example embodiment where the example operational flow 5700 of FIG. 57 may include at least one additional operation. Additional operations may include an operation 5810 .
  • Operation 5810 illustrates containing the inhalable compound in a reservoir.
  • the compound 104 may be contained in the reservoir 180 .
  • FIG. 59 illustrates an operational flow 5900 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H , and/or with respect to other examples and contexts.
  • the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H .
  • the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • Operation 5910 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set.
  • the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154 .
  • operation 5920 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • the collar 100 may be maintained in an operable dispensing position with an adhesive 138 .
  • operation 5930 depicts supporting a hands-free aerosol delivery system on the body of a mammal.
  • the collar 100 may be supported on the body of the subject 102 .
  • FIG. 60 illustrates an operational flow 6000 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H , and/or with respect to other examples and contexts.
  • the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H .
  • the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • Operation 6010 depicts detecting a medical condition parameter of a mammal according to a medical condition parameter request.
  • the collar 100 may utilize a sensor module 170 to detect a medical condition parameter for the subject 102 according to a request from a physician 168 .
  • the request may be received via the interface 164 and then transferred to the sensor module 170 via the processor 156 .
  • operation 6020 depicts maintaining in physical association with a user a hands-free article for dispensing an inhalable compound in an operable dispensing position.
  • the collar 100 may be maintained in an operable dispensing position with an adhesive 138 .
  • operation 6030 depicts dispensing for inhalation by the user a dose of an inhalable compound according to a dosing instruction set.
  • the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154 .
  • FIG. 61 illustrates an operational flow 6100 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 61 illustrates an example embodiment where the example operational flow 6000 of FIG. 60 may include at least one additional operation. Additional operations may include an operation 6110 .
  • Operation 6110 illustrates recording the detected medical condition parameter data. It will be appreciated that a sleep state may be included as a medical condition. For example, as shown in FIGS. 1A through 1H , the detected medical condition data may be recorded to the memory 154 .
  • FIG. 62 illustrates an operational flow 6200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 62 illustrates an example embodiment where the example operational flow 6000 of FIG. 60 may include at least one additional operation. Additional operations may include an operation 6210 , an operation 6212 , and/or an operation 6214 .
  • Operation 6210 illustrates transferring the detected medical condition parameter data.
  • the detected medical condition data stored in the memory 154 may be transferred to a flash drive 64 .
  • the operation 6212 illustrates transferring the detected medical condition parameter data to a flash drive.
  • the detected medical condition data stored in the memory 154 may be transferred to a flash drive 64 .
  • the operation 6214 illustrates transferring the detected medical condition parameter data to a hard drive.
  • the detected medical condition data stored in the memory 154 may be transferred to a hard drive 66 .
  • FIG. 63 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 63 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6302 .
  • the operation 6302 illustrates downloading the detected medical condition parameter data to a RAM.
  • the detected medical condition data stored in the memory 154 may be downloaded to a random access memory (RAM) 68 .
  • the detected medical condition data may be transmitted to a processor (e.g., processor 156 ).
  • the detected medical condition may be transmitted to an external site (e.g., the medical response unit 192 ).
  • FIG. 64 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 64 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6402 , and/or an operation 6404 .
  • the operation 6402 illustrates transmitting the detected medical condition parameter to a dispensing module.
  • the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 .
  • the operation 6404 illustrates transmitting the detected medical condition parameter to a dispensing module via a wireless transmission.
  • the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 wirelessly.
  • FIG. 65 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 65 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6502 .
  • the operation 6502 illustrates transmitting the detected medical condition parameter to a dispensing module via a wire transmission. For example, as shown in FIGS. 1A through 1H , the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a wired connection.
  • FIG. 66 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 66 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6602 .
  • the operation 6602 illustrates transmitting the detected medical condition parameter to a dispensing module via a radio transmission. For example, as shown in FIGS. 1A through 1H , the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a radio signal.
  • FIG. 67 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 67 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6702 .
  • the operation 6702 illustrates transmitting the detected medical condition parameter to a dispensing module via an optical transmission. For example, as shown in FIGS. 1A through 1H , the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via an optical transmission.
  • FIG. 68 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62 .
  • FIG. 68 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6802 .
  • the operation 6802 illustrates transmitting the detected medical condition parameter to a dispensing module via a mechanical transmission. For example, as shown in FIGS. 1A through 1H , the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a mechanical transmission.
  • the collar 100 may include a metered dose inhaler for delivering a metered dosage of an inhaled bronchodilator when the sensor module 170 detects a condition (e.g., an asthmatic incident including narrowing of the subject's airways) or a symptom indicative of a condition (e.g., narrowing of the subject's airways, wheezing, or decreased exhalation volume).
  • a condition e.g., an asthmatic incident including narrowing of the subject's airways
  • a symptom indicative of a condition e.g., narrowing of the subject's airways, wheezing, or decreased exhalation volume.
  • the sensor module 170 transmits the detected condition or symptom to the processor 156 .
  • the processor 156 utilizes information stored in the memory 154 to determine the most appropriate course of action for the detected condition/symptom.
  • the memory 154 may include instructions for dispensing (e.g., via the dispensing module 128 ) a metered dose of the inhaled bronchodilator (which is stored in reservoir 180 ) when the incident is detected.
  • the memory 154 includes instructions for subsequent administration of the bronchodilator at some time after the initial condition/symptom is detected (e.g., in the case of a late-phase allergic reaction).
  • the memory 154 may also include instructions for activating a visual indicator 196 so that the subject 102 or an observer may be alerted to the subject's condition.
  • an implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
  • any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary.
  • Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
  • logic and similar implementations may include software or other control structures.
  • Electronic circuitry may have one or more paths of electrical current constructed and arranged to implement various functions as described herein.
  • one or more media may be configured to bear a device-detectable implementation when such media hold or transmit device detectable instructions operable to perform as described herein.
  • implementations may include an update or modification of existing software or firmware, or of gate arrays or programmable hardware, such as by performing a reception of or a transmission of one or more instructions in relation to one or more operations described herein.
  • an implementation may include special-purpose hardware, software, firmware components, and/or general-purpose components executing or otherwise invoking special-purpose components. Specifications or other implementations may be transmitted by one or more instances of tangible transmission media as described herein, optionally by packet transmission or otherwise by passing through distributed media at various times.
  • implementations may include executing a special-purpose instruction sequence or invoking circuitry for enabling, triggering, coordinating, requesting, or otherwise causing one or more occurrences of virtually any functional operations described herein.
  • operational or other logical descriptions herein may be expressed as source code and compiled or otherwise invoked as an executable instruction sequence.
  • implementations may be provided, in whole or in part, by source code, such as C++, or other code sequences.
  • source or other code implementation may be compiled//implemented/translated/converted into a high-level descriptor language (e.g., initially implementing described technologies in C or C++ programming language and thereafter converting the programming language implementation into a logic-synthesizable language implementation, a hardware description language implementation, a hardware design simulation implementation, and/or other such similar mode(s) of expression).
  • a high-level descriptor language e.g., initially implementing described technologies in C or C++ programming language and thereafter converting the programming language implementation into a logic-synthesizable language implementation, a hardware description language implementation, a hardware design simulation implementation, and/or other such similar mode(s) of expression.
  • a logical expression e.g., computer programming language implementation
  • a Verilog-type hardware description e.g., via Hardware Description Language (HDL) and/or Very High Speed Integrated Circuit Hardware Descriptor Language (VHDL)
  • VHDL Very High Speed Integrated Circuit Hardware Descriptor Language
  • Those skilled in the art will recognize how to obtain, configure, and optimize suitable transmission or computational elements, material supplies, actuators, or other structures in light of these teachings.
  • Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link (e.g., transmitter, receiver, transmission logic, reception logic, etc.), etc.).
  • a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.
  • a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link (e.g., transmitter, receiver, transmission logic, reception
  • electro-mechanical system includes, but is not limited to, electrical circuitry operably coupled with a transducer (e.g., an actuator, a motor, a piezoelectric crystal, a Micro Electro Mechanical System (MEMS), etc.), electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of memory (e.g., random access, flash, read only, etc.)), electrical circuitry forming a communications device (e.g., a modem, communications switch, optical-electrical equipment, etc.), and/or any non-mechanical device.
  • a transducer
  • electro-mechanical systems include but are not limited to a variety of consumer electronics systems, medical devices, as well as other systems such as motorized transport systems, factory automation systems, security systems, and/or communication/computing systems.
  • electro-mechanical as used herein is not necessarily limited to a system that has both electrical and mechanical actuation except as context may dictate otherwise.
  • electrical circuitry includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of memory (e.g., random access, flash, read only, etc.)), and/or electrical circuitry forming a communications device (e.g.,
  • a data processing system generally includes one or more of a system unit housing, a video display device, memory such as volatile or non-volatile memory, processors such as microprocessors or digital signal processors, computational entities such as operating systems, drivers, graphical user interfaces, and applications programs, one or more interaction devices (e.g., a touch pad, a touch screen, an antenna, etc.), and/or control systems including feedback loops and control motors (e.g., feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities).
  • a data processing system may be implemented utilizing suitable commercially available components, such as those typically found in data computing/communication and/or network computing/communication systems.
  • user 166 is shown/described herein as a single illustrated figure, those skilled in the art will appreciate that user 166 may be representative of a human user, a robotic user (e.g., computational entity), and/or substantially any combination thereof (e.g., a user may be assisted by one or more robotic agents) unless context dictates otherwise.
  • a robotic user e.g., computational entity
  • substantially any combination thereof e.g., a user may be assisted by one or more robotic agents
  • Those skilled in the art will appreciate that, in general, the same may be said of “sender” and/or other entity-oriented terms as such terms are used herein unless context dictates otherwise.
  • any two components so associated can also be viewed as being “operably connected”, or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable,” to each other to achieve the desired functionality.
  • operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components.
  • one or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc.
  • configured to can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.

Abstract

A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application is related to and claims the benefit of the earliest available effective filing date(s) from the following listed application(s) (the “Related Applications”) (e.g., claims earliest available priority dates for other than provisional patent applications or claims benefits under 35 USC §119(e) for provisional patent applications, for any and all parent, grandparent, great-grandparent, etc. applications of the Related Application(s)). All subject matter of the Related Applications and of any and all parent, grandparent, great-grandparent, etc. applications of the Related Applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.
    • Related Applications:
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Dec. 30, 2008, application Ser. No. 12/317,934, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Dec. 31, 2008, application Ser. No. 12/319,143, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Feb. 12, 2009, application Ser. No. 12/378,284, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Feb. 13, 2009, application Ser. No. 12/378,485, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Feb. 20, 2009, application Ser. No. 12/380,013, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Feb. 23, 2009, application Ser. No. 12/380,108, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Feb. 27, 2009, application Ser. No. 12/380,587, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Mar. 2, 2009, application Ser. No. 12/380,679, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Mar. 25, 2009, application Ser. No. 12/383,509, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Mar. 26, 2009, application Ser. No. 12/383,819, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Mar. 31, 2009, application Ser. No. 12/384,104, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 1, 2009, application Ser. No. 12/384,203, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 20, 2009, application Ser. No. 12/386,574, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 21, 2009, application Ser. No. 12/386,669, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 27, 2009, application Ser. No. 12/387,057, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 28, 2009, application Ser. No. 12/387,151, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed Apr. 30, 2009, application Ser. No. 12/387,321, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of United States Patent Application entitled METHODS AND SYSTEMS FOR PRESENTING AN INHALATION EXPERIENCE, naming RODERICK A. HYDE; ROBERT LANGER; ERIC C. LEUTHARDT; ROBERT W. LORD; ELIZABETH A. SWEENEY; CLARENCE T. TEGREENE; AND LOWELL L. WOOD as inventors, filed May 1, 2009, application Ser. No. 12/387,472, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • The United States Patent Office (USPTO) has published a notice to the effect that the USPTO's computer programs require that patent applicants reference both a serial number and indicate whether an application is a continuation or continuation-in-part. Stephen G. Kunin, Benefit of Prior-Filed Application, USPTO Official Gazette Mar. 18, 2003, available at http://www.uspto.gov/web/offices/com/sol/og/2003/week11/patbene.htm. The present Applicant Entity (hereinafter “Applicant”) has provided above a specific reference to the application(s) from which priority is being claimed as recited by statute. Applicant understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization, such as “continuation” or “continuation-in-part,” for claiming priority to U.S. patent applications. Notwithstanding the foregoing, Applicant understands that the USPTO's computer programs have certain data entry requirements, and hence Applicant is designating the present application as a continuation-in-part of its parent applications as set forth above, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).
    • SUMMARY
  • In an aspect, a method includes, but is not limited to, dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In an aspect, a method includes, but is not limited to, dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and receiving a dose of an inhalable compound for dispensing. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In an aspect, a method includes dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and receiving the inhalable compound. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In an aspect, a method includes dispensing a dose of an inhalable compound according to a dosing instruction set; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and supporting a hands-free aerosol delivery system on the body of a mammal. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In an aspect, a method includes detecting a medical condition parameter of a mammal according to a medical condition parameter request; maintaining a hands-free article for dispensing an inhalable compound in an operable dispensing position; and dispensing a dose of an inhalable compound according to a dosing instruction set. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In addition to the foregoing, various other method and/or system and/or program product aspects are set forth and described in the teachings such as text (e.g., claims and/or detailed description) and/or drawings of the present disclosure.
  • The foregoing is a summary and thus may contain simplifications, generalizations, inclusions, and/or omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is NOT intended to be in any way limiting. Other aspects, features, and advantages of the devices and/or processes and/or other subject matter described herein will become apparent in the teachings set forth herein.
    • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1A is a front elevation view illustrating a collar for dispensing one or more inhalable compounds.
  • FIG. 1B is a top plan view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1C is a partial cross-sectional side elevation view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1D is a partial cross-sectional side elevation view of a collar for dispensing one or more inhalable compounds.
  • FIG. 1E is a schematic of a collar for dispensing one or more inhalable compounds.
  • FIG. 1F is a schematic of a compound for being dispensed by a collar for dispensing one or more inhalable compounds.
  • FIG. 1G is a schematic of a compound for being dispensed by a collar for dispensing one or more inhalable compounds.
  • FIG. 1H is a schematic of a collar for dispensing one or more inhalable compounds, where the collar is connected to various storage media.
  • FIG. 2 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 3 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 4 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 5 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 6 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 7 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 8 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 9 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 10 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 11 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 12 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 13 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 14 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 15 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 16 illustrates an alternative embodiment of the operational flow of FIG. 56.
  • FIG. 17 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 18 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 19 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 20 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 21 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 22 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 23 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 24 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 25 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 26 illustrates an alternative embodiment of the operational flow of FIG. 57.
  • FIG. 27 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 28 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 29 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 30 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 31 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 32 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 33 illustrates an alternative embodiment of the operational flow of FIG. 59.
  • FIG. 34 illustrates an alternative embodiment of the operational flow of FIG. 60.
  • FIG. 35 illustrates an alternative embodiment of the operational flow of FIG. 60.
  • FIG. 36 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 37 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 38 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 39 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 40 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 41 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 42 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 43 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 44 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 45 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 46 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 47 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 48 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 49 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 50 illustrates an alternative embodiment of the operational flow of FIG. 49.
  • FIG. 51 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 52 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 53 illustrates an alternative embodiment of the operational flow of FIG. 2.
  • FIG. 54 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 55 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 56 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 57 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 58 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 59 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 60 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 61 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 62 illustrates an operational flow representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position.
  • FIG. 63 illustrates an alternative embodiment of the operational flow of FIG. 62.
  • FIG. 64 illustrates an alternative embodiment of the operational flow of FIG. 62.
  • FIG. 65 illustrates an alternative embodiment of the operational flow of FIG. 62.
  • FIG. 66 illustrates an alternative embodiment of the operational flow of FIG. 62.
  • FIG. 67 illustrates an alternative embodiment of the operational flow of FIG. 62.
  • FIG. 68 illustrates an alternative embodiment of the operational flow of FIG. 62.
    •  DETAILED DESCRIPTION
  • In the following detailed description, reference is made to the accompanying drawings, which form a part hereof. In the drawings, similar symbols typically identify similar components, unless context dictates otherwise. The illustrative embodiments described in the detailed description, drawings, and claims are not meant to be limiting. Other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented here.
  • Referring generally to FIGS. 1A through 1H, a hands-free article for dispensing one or more inhalable compounds is described in accordance with the present disclosure. The hands-free article, such as collar 100, may be worn by a subject 102 who can inhale a compound 104 dispensed by the collar 100. Although the subject 102 is depicted as a human in the accompanying figures, the subject can generally include any biological entity having respiratory organs (e.g., lungs), such as a mammalian entity (e.g., a human, a dog, a lion, or another mammal), an avian entity (e.g., a bird of prey or another avian), an amphibian entity (e.g., a frog or another amphibian), a reptilian entity (e.g., an alligator, a crocodile, a tortoise, or another reptile), as well as other biological entities having respiratory organs.
  • The collar 100 is maintained in an operable dispensing position. For example, the collar 100 may comprise a support for a hands-free aerosol delivery system on the body of a mammal. Thus, the collar 100 may be disposed around a portion of the body of the subject 102. For example, in one embodiment, the collar 100 may encircle a neck portion 106 of the subject 102. In an embodiment, the collar 100 may encircle a limb portion (e.g., wrist portion 108) of the subject 102. In an embodiment, the collar 100 may encircle a torso portion (e.g., chest portion 110) of the subject 102. In an embodiment, the collar 100 may encircle a head portion 112 of the subject 102. It should be noted that the above-mentioned embodiments are provided by way of example and are not meant to be limiting of the present disclosure. Thus, it is contemplated that the collar 100 may be maintained in an operable dispensing position by attaching it to a variety of other portions of the body of the subject 102.
  • The collar 100 may comprise a support member having a first end 114 and a second end 116. The first end 114 may be connected to the second end 116, encircling and creating a closed loop (e.g., a circle) about the body part of the subject 102. In an embodiment, the first end 114 may be connected to the second end 116 via a magnet 118. In an embodiment, the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a hook 120. In an embodiment, the first end 114 may be connected to the second end 116 via a snap connection 122. In an embodiment, the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a threaded connection 124. In an embodiment, the first end 114 may be connected to the second end 116 via a belt-like connection 126. It will be appreciated that this list of connections is provided by way of example and is not meant to be restrictive of the present disclosure. Other fastening devices may be utilized with the collar 100.
  • The collar 100 includes a dispensing module 128 for dispensing some amount of material, such as a dose (e.g., measured quantity, prescribed quantity, therapeutic quantity, etc.) of a compound 104 (e.g., organic compound, pharmaceutical compound, therapeutic compound, homeopathic compound, nutraceutical compound, biological material, protein, nucleic acid, cell, peptide, etc.) for modulating, curing, diagnosing, mitigating, preventing, or treating one or more of a disease, disorder, symptom or a condition. Additionally, the compound 104 may be utilized for enhancing one or more of a physical well-being or a mental well-being. The dispensing module 128 may be oriented in order to optimize delivery of the compound 104 to the subject 102. For example, in the case of an inhalable compound, the dispensing module may be oriented to optimize respiratory receipt by the subject 102. This may include orienting the dispensing module 128 such that an outlet (nozzle) 130 or jet emanating from the dispensing module 128 is pointed at (oriented towards) the nose 132 or mouth 134 of the subject 102.
  • Some inhalable compounds for utilization with the collar 100 may include, but are not limited to inhalable insulin, an inhalable corticosteroid, an inhalable antibiotic, an inhalable beta-2 agonist, or an inhalable mast cell stabilizer. Further, compounds for utilization with the collar 100 may include a compound that acts locally or systemically. Compounds for utilization with the collar 100 may include a compound having a formulation such that the formulation includes a carrier, such as a gas carrier, a liquid carrier, or a solid carrier. Additionally, compounds for utilization with the collar 100 may include a compound having a formulation such that the formulation includes penetration or absorption enhancers. It should be noted that this list is provided by way of example only and is not meant to be restrictive of the present invention. Further, it will be appreciated that various mechanisms or compounds may be utilized to power (e.g., nebulize) the inhalable compound out of the collar 100, such as O2 (oxygen) or helium-O2 (heliox). Such compounds may be selected for improving the response of the subject (e.g., heliox when utilized with an inhaled bronchodilator such as an inhalable beta-2 agonist).
  • Further, the dispensing module 128 may be maintained in an optimal position for optimizing delivery of the compound 104 to the subject 102. In an embodiment, a relative position or direction to a desired respiratory target is determined. For example, a direction to the subject's nose 132 may be determined. In an embodiment, a position of the dispensing module 128 may then be maintained for optimizing delivery of the compound 104. For example, the orientation of the outlet 130 may be maintained in the direction determined for the subject's nose 132. In an embodiment, the position of the dispensing module 128 may be maintained via a weight 136. In an embodiment, the position of the dispensing module may be maintained via an adhesive 138. In an embodiment, the position of the dispensing module 128 may be maintained via a slide 140. In an embodiment, the position of the dispensing module 128 may be maintained via a magnet 142. In an embodiment, the position of the dispensing module 128 may be maintained via a fastener 144 (e.g., a button or a snap). In an embodiment, the position of the dispensing module 128 may be maintained via a spring 146. It will be appreciated that this list is provided by way of example and is not meant to be restrictive of the present disclosure.
  • The delivery of the compound 104 can be controlled to optimize or regulate delivery of the material 104 to the subject 102. The delivery mechanism can be one or more of the same type of material delivery system (e.g., nebulizer), or may include at least two different delivery systems (e.g., nebulizer and a dry powder inhaler), the at least one outlet 130 may be one of a suite or an array of outlets (e.g., nozzles) 148. One or more outlets (e.g., the first nozzle 130 and a second nozzle 150) may be selected to deliver the compound 104. In an embodiment, the first and second nozzles 130 and 150 may be in different locations. The direction of the subject's nose 132 may be determined. Then, a discharge direction for the dispensing module 128 can be controlled for optimizing delivery of the compound 104. For example, the orientation of the dispensing module 128 can be controlled to orient the first outlet 130 and the second outlet 150 in the direction determined for the subject's nose 132. In an embodiment, directed delivery of the compound 104 may be accomplished via a demand valve 152 coupled with programmable dosing. In an embodiment, directed delivery of the compound 104 may be accomplished via a charged particle dispersion. In an embodiment, the first outlet 130, the second outlet 150, or the suite of outlets 148 may include outlets having variable discharge characteristics, such as directional, volumetric, spray area, or other characteristics.
  • Various mechanical systems for delivering inhalable materials may include, but are not limited to, a vaporizer (e.g., a device for vaporizing liquid material for inhalation), a nebulizer (e.g., a device for administering material in the form of a mist for inhalation), a liquid aerosol system (e.g., a system for propelling fine droplets of material utilizing a gas), a dry powder inhalation system, an atomizer (e.g., a device for reducing a liquid material to a spray or vapor for inhalation), a metered dose inhaler (e.g., a device for releasing a metered dose of material for inhalation), a propellant-delivered system, a piezo-electric inhaler (e.g., an inhaler utilizing a piezo vibrator to deaggregate a material powder for subsequent inhalation by the subject), etc. It is further contemplated that the material 104 may be provided in removable or replaceable storage units. For example, the material 104 may be provided in an easily replaceable dose packet. In an embodiment, the material 104 may be provided in a removable canister. It will be appreciated that these storage units are provided by way of example, and other various storage configurations having varying shapes, sizes, and form factors may be utilized with the collar 100.
  • Following are a series of flowcharts depicting implementations. For ease of understanding, the flowcharts are organized such that the initial flowcharts present implementations via an example implementation and thereafter the following flowcharts present alternate implementations and/or expansions of the initial flowchart(s) as either sub-component operations or additional component operations building on one or more earlier-presented flowcharts. Those having skill in the art wilt appreciate that the style of presentation utilized herein (e.g., beginning with a presentation of a flowchart(s) presenting an example implementation and thereafter providing additions to and/or further details in subsequent flowcharts) generally allows for a rapid and easy understanding of the various process implementations. In addition, those skilled in the art will further appreciate that the style of presentation used herein also lends itself well to modular and/or object-oriented program design paradigms.
  • FIG. 2 illustrates an operational flow 200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. In FIG. 2 and in following figures that include various examples of operational flows, discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H, and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H. Also, although the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • After a start operation, the operational flow 200 moves to an operation 210. Operation 210 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a memory 154 for storing a dosing instruction set. The memory 154 may be connected to a processor 156 operatively configured for initiating the dispensing of a dose 158 of a compound 104. In an embodiment, the processor 156 is connected to a pump 160. The processor 156 may electronically signal the pump 160 to dispense the dose 158 of the compound 104.
  • Then, operation 220 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position. For example, as shown in FIGS. 1A through 1H, the collar 100 may be maintained in an operable position by positioning a weight 136 at one end of the collar 100.
  • FIG. 3 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 3 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 302, an operation 304, an operation 306, and/or an operation 308.
  • The operation 302 illustrates dispensing a dose of an inhalable compound according to a defined dosing instruction set. For example, as shown in FIGS. 1A through 1H, the memory 154 may store a defined dosing instruction set, and a processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the dosing instruction set. Further, the operation 304 illustrates dispensing a dose of an inhalable compound according to a time defined dosing instruction set. For example, as shown in FIGS. 1A through 1H, the memory 154 may store a time defined dosing instruction set, and the processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the time defined dosing instruction set. In an embodiment, the processor 156 is connected to a time keeping module 162 for determining when to dispense the compound 104. For example, the compound 104 may be dispensed while the subject 102 is sleeping (or is scheduled to steep according to the time defined dosing instruction set). Alternatively, the compound 104 may be dispensed shortly before the subject is scheduled to sleep (e.g., in the case of a compound including a sleep aid, or the like). Further, the operation 306 illustrates dispensing a dose of an inhalable compound according to a user defined dosing instruction set. For example, as shown in FIGS. 1A through 1H, the memory 154 may store a user defined dosing instruction set, and the processor 156 coupled with the memory 154 may be configured for initiating dispensing of the compound 104 according to the user defined dosing instruction set. In an embodiment, the collar 100 may include an interface 164 accessible by a user 166 for supplying the user defined dosing instruction set to the memory 154 (e.g., via the processor 156). Further, the operation 308 illustrates dispensing a dose of an inhalable compound according to a health care provider-defined dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may include an interface 164 accessible by a physician 168 for supplying a physician defined dosing instruction set to the memory 154 (e.g., via the processor 156).
  • FIG. 4 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 4 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 402, an operation 404, an operation 406, and/or an operation 408. Further, the operation 402 illustrates dispensing a dose of an inhalable compound according to a need response dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a memory 154 for storing a need response dosing instruction set. The collar 100 may also include a transducer (e.g., a sensor module 170) for sensing a health or wellness-related characteristic (or another characteristic) of the subject 102. Based on the sensed characteristic of the subject 102, the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the characteristic corresponds to a need stored in the need response dosing instruction set. In one instance, a sensed characteristic includes a blood glucose level, and the need response dosing instruction set includes instructions for dispensing a dose of the compound when the sensed blood glucose level is above a certain threshold. Further, the operation 404 illustrates dispensing a dose of an inhalable compound according to an environmental need response dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a memory 154 for storing an environmental need response dosing instruction set. The collar 100 may also include a sensor module 170 for sensing an environment occupied by the subject 102. Based on the sensed environment of the subject 102, the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the environment corresponds to an environment stored in the environmental need response dosing instruction set. In an embodiment, the sensed environment may include sensing an actual or likely trigger (e.g., an allergen, a chemical, an irritant, or a particulate). A likely trigger may include, for example, a sensed environment where the presence of an animal increases a likelihood of dander, or an outside environment where a time of year (e.g., the month of May) increases a likelihood of pollen exposure. In one instance, a sensed environment includes an outdoor environment, and the environment need response dosing instruction set includes instructions for dispensing a dose of the compound when the outdoor environment is sensed. In an embodiment, the sensed environment includes at least one other individual (and possibly a number of other individuals, e.g., a crowd), and the environmental need response dosing instruction set includes instructions for dispensing a dose of a vaccine when the other individual is sensed. In an embodiment, the environmental need response dosing instruction set includes instructions for dispensing a dose of a calming agent or anti-anxiety medication when one or more other individuals are sensed. In an embodiment, the sensed environment does not include another individual, and the environmental need response dosing instruction set includes instructions for dispensing a dose of a vaccine when the absence of other individuals is sensed. Further, the operation 406 illustrates dispensing a dose of an inhalable compound according to a location need response dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a memory 154 for storing a location need response dosing instruction set. The collar 100 may also include a sensor module 170 for sensing a location occupied by the subject 102. Based on the sensed location of the subject 102, the processor 156 may be operatively configured to dispense the dose 158 of the compound 104 after verifying that the location corresponds to a location stored in the location need response dosing instruction set. In one instance, a sensed location includes a school zone, and the location need response dosing instruction set includes instructions for dispensing a dose of the compound when the school zone is sensed. In another instance, the sensed location includes a living space, and the location need response dosing instruction set includes instructions for dispensing a dosage of a pheromone (or another substance) for preventing a pet from urinating in the living space. Alternatively, the sensed location may include a litter box, and the dosing instruction set may include instructions for dispensing a pheromone (or another substance) for enticing a pet to defecate in the litter box. Further, the operation 408 illustrates dispensing the inhalable compound in accordance with a dispensing order received by a dispensing module. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from the processor 156.
  • In an embodiment, the dispensing order may be dispatched upon the sensor module 170 detecting a condition of the subject, such as an asthmatic incident (e.g., a narrowing of the subject's airways). In an embodiment, the sensor module 170 may identify a symptom of an asthmatic incident, such as a subject experiencing trouble breathing, a sneeze, a cough, a wheeze, a rhonchus, or a snore. In an embodiment, the sensor module 170 may identify a physical condition associated with an asthmatic incident, such as a narrowing of the subject's airways. Other symptoms or conditions detected by the sensor module 170 may include, but are not limited to, Chronic Obstructive Pulmonary Disease (COPD), bronchitis, abnormally high blood glucose level, etc. Further, it will be appreciated that the processor 156 may determine the most effective route of administration for a material based upon a particular condition or set of symptoms. In an embodiment, the processor 156 may determine that an inhalation route of delivery including the nasal cavity is a most effective route of treatment for an asthmatic incident, and may instruct administration of the dose 158 of the material 104 accordingly (e.g., in a case where the dose 158 includes a beta-2 agonist.) In an embodiment, the processor 156 may be programmed to determine whether a to-be-delivered agent should be provided to the subject via intra-nasal administration or inhalation, or both. For example, for a desired delivery of an agent to the brain of the subject, the device may be programmed to administer such agent through intranasal administration.
  • FIG. 5 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 5 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 502, an operation 504, and/or an operation 506.
  • The operation 502 illustrates dispensing a dose of a nutraceutical compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a nutraceutical compound 172.
  • The operation 504 illustrates dispensing a dose of a therapeutic compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a therapeutic compound 174.
  • The operation 506 illustrates dispensing a dose of a homeopathic compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a homeopathic compound 176.
  • FIG. 6 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 6 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 602, an operation 604, and/or an operation 606.
  • The operation 602 illustrates generating an aerosol of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include an aerosol which may be dispensed via the nozzle 130.
  • The operation 604 illustrates generating at least one of a vapor or a powder of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a vapor which may be dispensed via the suite of nozzles 148. Alternatively, the compound 104 may include a powder, which may be dispensed via the suite of nozzles 148. Generating a powder may include, for example, generating particles, fine particles, micronized particles, microparticles, or particulates.
  • The operation 606 illustrates generating a liquid atomization of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include an atomized liquid which may be dispensed via the nozzle 130.
  • FIG. 7 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 7 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 702, an operation 704, an operation 706, and/or an operation 708.
  • The operation 702 illustrates administering the inhalable compound via spraying a compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may be sprayed via the nozzle 130.
  • The operation 704 illustrates administering the inhalable compound via at least one of dusting or powderizing a compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may be dusted via the nozzle 130. Powderizing the compound may include, for example, de-agglomeration, or particularizing.
  • The operation 706 illustrates administering the inhalable compound via nebulizing a compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may be nebulized and dispensed via the nozzle 130.
  • The operation 708 illustrates administering the inhalable compound via vaporizing a compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may be vaporized and dispensed via the nozzle 130.
  • In an embodiment, the inhalable compound may include a carrier. For example, a carrier may include a gas carrier, a liquid carrier, or a solid carrier. In embodiments, the carrier may include a hydrocarbon, a fluorocarbon, a propellant, a salt, a saccharide, a lipid, a liposome, a synthetic, or a natural polymer. Further, various formulations including a carrier may include penetration or absorption enhancers.
  • FIG. 8 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 8 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 802, an operation 804, an operation 806, and/or an operation 808.
  • The operation 802 illustrates receiving a dose of a pharmaceutical compound for dispensing. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a pharmaceutical compound 178. The pharmaceutical compound 178 may be stored in a reservoir 180 of the collar 100. The reservoir 180 may receive one or more doses of the pharmaceutical compound 178 for dispensing.
  • The operation 804 illustrates receiving a dose of a therapeutic compound for dispensing. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a therapeutic compound 174. The therapeutic compound 174 may be stored in a reservoir 180 of the collar 100. The reservoir 180 may receive one or more doses of the therapeutic compound 174 for dispensing. Further, the operation 806 illustrates receiving a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the dosing instruction set may be received via the interface 164. Further, the operation 808 illustrates receiving a dosing instruction set via a wireless transmission. For example, as shown in FIGS. 1A through 1H, the dosing instruction set may be received via the interface 164, which may include a wireless interface for receiving a wireless transmission.
  • FIG. 9 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 9 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 902, and/or an operation 904. Further, the operation 902 illustrates receiving a dosing instruction set via a processor. For example, as shown in FIGS. 1A through 1H, the processor 156 may receive a dosing instruction set. Further, the operation 904 illustrates receiving a dosing instruction set via a connectable device containing digital instructions or data. For example, as shown in FIGS. 1A through 1H, the collar 100 may receive a dosing instruction set from a connectable device 182 (e.g., a laptop computer, a personal digital assistant (PDA), or a cellular telephone).
  • FIG. 10 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 10 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1002, and/or an operation 1004. Further, the operation 1002 illustrates receiving a dosing instruction set via a wire transmission. For example, as shown in FIGS. 1A through 1H, the device 182 may be connected to the interface 164 via a wired connection. Further, the operation 1004 illustrates receiving a dosing instruction set via an optical transmission. For example, as shown in FIGS. 1A through 1H, the device 182 may be connected to the interface 164 via an optical connection. For instance, the device 182 may include an optical transmitter (e.g., a light), and the interface 164 may include an optical receiver (e.g., a light sensor).
  • FIG. 11 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 11 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1102, and/or an operation 1104. Further, the operation 1102 illustrates receiving a dosing instruction set via a radio transmission. For example, as shown in FIGS. 1A through 1H, the device 182 may be connected to the interface 164 via a radio connection. For instance, the device 182 may include a Radio Frequency (RF) transmitter, and the interface 164 may include an RF receiver. Further, the operation 1104 illustrates receiving a dosing instruction set via a mechanical transmission. For example, as shown in FIGS. 1A through 1H, the device 182 may be connected to the interface 164 via a mechanical connection.
  • FIG. 12 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 12 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1202, and/or an operation 1204. Further, the operation 1202 illustrates receiving a dosing instruction set from a user. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a user 166. Further, the operation 1204 illustrates receiving a dosing instruction set from a health care provider. A health care provider may include, for example, a physician, a physician's assistant, a nurse, a nurse practitioner, a pharmacist, or an emergency medical technician. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a physician 168.
  • FIG. 13 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 13 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1302, and/or an operation 1304. Further, the operation 1302 illustrates receiving a dosing instruction set from a pharmacist. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a pharmacist 184. Further, the operation 1304 illustrates receiving a dosing instruction set from at least one of a parent or a guardian. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a parent 186.
  • FIG. 14 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 14 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1402, and/or an operation 1404. Further, the operation 1402 illustrates receiving a dosing instruction set from at least one of a pet owner, an animal researcher, or an animal owner. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a pet owner 188. Further, the operation 1404 illustrates receiving a dosing instruction set from a veterinarian health care provider. A veterinarian health care provider may include, among others, a veterinarian, a veterinarian's assistant, or a veterinarian technician. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a veterinarian 190. In an embodiment, the interface 164, may be utilized to receive a dosing instruction set from a researcher.
  • FIG. 15 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 15 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1502. Further, the operation 1502 illustrates receiving a dosing instruction set from a medical response unit. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a medical response unit 192.
  • FIG. 16 illustrates alternative embodiments of the example operational flow 5600 of FIG. 56. FIG. 16 illustrates example embodiments where the operation 5630 may include at least one additional operation. Additional operations may include an operation 1602, and/or an operation 1604.
  • The operation 1602 illustrates receiving a dose of a homeopathic compound for dispensing. For example, as shown in FIGS. 1A through 1H, the compound 104 may include one or more homeopathic compounds 176.
  • The operation 1604 illustrates receiving a dose of a nutraceutical compound for dispensing. For example, as shown in FIGS. 1A through 1H, the compound 104 may include one or more nutraceutical compounds 172.
  • FIG. 17 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 17 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 1702, an operation 1704, and/or an operation 1706.
  • The operation 1702 illustrates receiving the inhalable compound in a reservoir. For example, as shown in FIGS. 1A through 1H, the compound 104 may be received in a reservoir 180. Further, the operation 1704 illustrates monitoring a quantity of the inhalable compound in the reservoir. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to monitor the compound 104 in the reservoir 180. Further, the operation 1706 illustrates logging a quantity of the inhalable compound in the reservoir. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to monitor the compound 104 in the reservoir 180, and the memory 154 may be utilized to keep a log of a quantity of the compound 104 in the reservoir 180.
  • FIG. 18 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 18 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 1802, and/or an operation 1804. Further, the operation 1802 illustrates logging a quantity of the inhalable compound dispensed from the reservoir. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to monitor an amount of the compound 104 dispensed from the reservoir 180, and the memory 154 may be utilized to keep a log of a quantity of the compound 104 dispensed from the reservoir 180. Further, the operation 1804 illustrates logging a time of the inhalable compound dispensed from the reservoir. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to monitor a time of dispensing the compound 104 from the reservoir 180 (e.g., by utilizing the time keeping module 162), and the memory 154 may be utilized to keep a log of a time of dispensing the compound 104 from the reservoir 180.
  • FIG. 19 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 19 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 1902, and/or an operation 1904. Further, the operation 1902 illustrates logging a dispersion pattern of the inhalable compound dispensed from the reservoir. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a camera 194 for monitoring a dispersion pattern of the dispensed compound 104, and the memory 154 may be utilized to log the dispersion pattern. Further, the operation 1904 illustrates logging a species of the inhalable compound dispensed from the reservoir. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to determine a species of the compound 104 dispensed from the reservoir 180, and the memory 154 may be utilized to log the determined species.
  • FIG. 20 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 20 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2002. Further, the operation 2002 illustrates transmitting a set of logged reservoir information to an external location. For example, as shown in FIGS. 1A through 1H, the information logged by the memory 154 may be transmitted to an external location via the interface 164.
  • FIG. 21 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 21 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2102, and/or an operation 2104. Further, the operation 2102 illustrates activating an alert when a quantity threshold of the inhalable compound in the reservoir is achieved. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a visual indicator 196 for issuing an alert when a quantity threshold of the compound 104 is achieved (e.g., as determined by the processor 156). Further, the operation 2104 illustrates activating a visual alert when a quantity threshold of the inhalable compound in the reservoir is achieved. For example, as shown in FIGS. 1A through 1H, the visual indicator 196 may be activated when a quantity threshold of the compound 104 is achieved.
  • FIG. 22 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 22 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2202. Further, the operation 2202 illustrates activating an auditory alert when a quantity threshold of the inhalable compound in the reservoir is achieved. For example, as shown in FIGS. 1A through 1H, the collar 100 may include an audible indicator 198 for issuing an auditory alert when a quantity threshold of the compound 104 is achieved.
  • FIG. 23 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 23 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2302. Further, the operation 2302 illustrates activating an electronic alert when a quantity threshold of the inhalable compound in the reservoir is achieved. For example, as shown in FIGS. 1A through 1H, the collar 100 may include an electronic indicator 50 for issuing an electronic alert when a quantity threshold of the compound 104 is achieved.
  • FIG. 24 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 24 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2402, an operation 2404, and/or an operation 2406.
  • The operation 2402 illustrates receiving the inhalable compound in a reloadable reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include one or more reloadable reservoirs.
  • The operation 2404 illustrates receiving the inhalable compound in at least one of a disposable reservoir or a multi-component reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include one or more disposable reservoirs.
  • The operation 2406 illustrates receiving the inhalable compound in a multi-compound reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include one or more compounds, such as a first compound 104 and a second compound.
  • FIG. 25 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 25 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2502, an operation 2504, and/or an operation 2506.
  • The operation 2502 illustrates receiving the inhalable compound in a single compound reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include a single compound, such as the first compound 104.
  • The operation 2504 illustrates receiving the inhalable compound in a dispensing reservoir. For example, as shown in FIGS. 1A through 1H, the compound 104 received in the reservoir 180 may be an inhalable compound.
  • The operation 2506 illustrates receiving the inhalable compound in a modular reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include a module reservoir.
  • FIG. 26 illustrates alternative embodiments of the example operational flow 5700 of FIG. 57. FIG. 26 illustrates example embodiments where the operation 5730 may include at least one additional operation. Additional operations may include an operation 2602, and/or an operation 2604.
  • The operation 2602 illustrates receiving the inhalable compound in a programmable reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include a programmable reservoir, which may be programmable via the processor 156.
  • The operation 2604 illustrates receiving the inhalable compound in a weighted reservoir. For example, as shown in FIGS. 1A through 1H, the reservoir 180 may include a weighted reservoir, which may be weighted with a weight 136.
  • FIG. 27 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 27 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2702, an operation 2704, and/or an operation 2706.
  • The operation 2702 illustrates disposing the hands-free aerosol delivery system substantially around a portion of the body of a mammal. For example, as shown in FIGS. 1A through 1H, the collar 100 may encircle the neck portion 106 of a subject 102. Further, the operation 2704 illustrates encircling a neck portion of the body of a mammal with a support member of the hands-free aerosol delivery device. For example, as shown in FIGS. 1A through 1H, the collar 100 may encircle the neck portion 106 of a subject 102. Further, the operation 2706 illustrates encircling a wrist portion of the body of a mammal with a support member of the hands-free aerosol delivery device. For example, as shown in FIGS. 1A through 1H, the collar 100 may encircle the wrist portion 108 of a subject 102.
  • FIG. 28 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 28 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2802, and/or an operation 2804. Further, the operation 2802 illustrates encircling a chest portion of the body of a mammal with a support member of the hands-free aerosol delivery device. For example, as shown in FIGS. 1A through 1H, the collar 100 may encircle a chest portion 110 of the subject 102. Further, the operation 2804 illustrates encircling a head portion of the body of a mammal with a support member of the hands-free aerosol delivery device. For example, as shown in FIGS. 1A through 1H, the collar 100 may encircle a head portion 112 of the subject 102.
  • FIG. 29 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 29 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 2902, and/or an operation 2904. Further, the operation 2902 illustrates connecting a first end of a support member of a hands-free aerosol delivery device to a second end of a support member of a hands-free aerosol delivery device while creating a circle about the body part of a mammal. For example, as shown in FIGS. 1A through 1H, the collar 100 may comprise a support member having a first end 114 and a second end 116. The first end 114 may be connected to the second end 116, encircling and creating a closed loop (e.g., a circle) about the body part of the subject 102. Further, the operation 2904 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a magnet. For example, as shown in FIGS. 1A through 1H, the first end 114 may be connected to the second end 116 via a magnet 118.
  • FIG. 30 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 30 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3002. Further, the operation 3002 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a hook. For example, as shown in FIGS. 1A through 1H, the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a hook 120.
  • FIG. 31 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 31 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3102. Further, the operation 3102 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a snap connection. For example, as shown in FIGS. 1A through 1H, the first end 114 may be connected to the second end 116 via a snap connection 122.
  • FIG. 32 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 32 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3202. Further, the operation 3202 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a threaded connection. For example, as shown in FIGS. 1A through 1H, the first end 114 of the collar 100 may be connected to the second end 116 of the collar 100 via a threaded connection 124.
  • FIG. 33 illustrates alternative embodiments of the example operational flow 5900 of FIG. 59. FIG. 33 illustrates example embodiments where the operation 5930 may include at least one additional operation. Additional operations may include an operation 3302. Further, the operation 3302 illustrates connecting the first end of a support member of the hands-free aerosol delivery device to the second end of a support member of the hands-free aerosol delivery device via a belt-like connection. For example, as shown in FIGS. 1A through 1H, the first end 114 may be connected to the second end 116 via a belt-like connection 126.
  • FIG. 34 illustrates alternative embodiments of the example operational flow 6000 of FIG. 60. FIG. 34 illustrates example embodiments where the operation 6010 may include at least one additional operation. Additional operations may include an operation 3402, an operation 3404, and/or an operation 3406.
  • The operation 3402 illustrates detecting a blood glucose level in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect a blood glucose level in the subject 102.
  • The operation 3404 illustrates detecting a blood oxygen level in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect a blood oxygen level in the subject 102.
  • The operation 3406 illustrates detecting an infection in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect an infection in the subject 102.
  • FIG. 35 illustrates alternative embodiments of the example operational flow 6000 of FIG. 60. FIG. 35 illustrates example embodiments where the operation 6010 may include at least one additional operation. Additional operations may include an operation 3502, an operation 3504, and/or an operation 3506.
  • The operation 3502 illustrates detecting vascular dysfunction in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect a vascular dysfunction in the subject 102.
  • The operation 3504 illustrates detecting blood flow in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect blood flow in the subject 102.
  • The operation 3506 illustrates detecting respiratory minute volume in the mammal. For example, as shown in FIGS. 1A through 1H, the sensor module 170 may be utilized to detect a respiratory volume in the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a sneeze of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a cough of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a wheeze of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a rhonchus of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a snore of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect a temperature (e.g., a body temperature) of the subject 102. In an embodiment, the sensor module 170 may be utilized to detect an expelled gas from the subject 102, such as a gas exhaled by the subject.
  • FIG. 36 illustrates an operational flow 3600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 36 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 3610.
  • After a start operation, an operation 210, and an operation 220, the operational flow 3600 moves to an operation 3610. Operation 3610 illustrates dispensing a dose of a pharmaceutical compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may be utilized to dispense a dose 158 of a pharmaceutical compound 178 to the subject 102.
  • FIG. 37 illustrates an operational flow 3700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 37 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 3710.
  • After a start operation, an operation 210, and an operation 220, the operational flow 3700 moves to an operation 3710. Operation 3710 illustrates directing issuance of a dispensing order. For example, as shown in FIGS. 1A through 1H, the processor 156 may direct issuance of a dispensing order (e.g., to the pump 160).
  • FIG. 38 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 38 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 3802, an operation 3804, and/or an operation 3806. Further, the operation 3802 illustrates accepting a dosing instruction set from a user. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a user 166. Further, the operation 3804 illustrates accepting a dosing instruction set from at least one of a physician, a health care provider, a physician's assistant, a nurse, a nurse practitioner, a registered nurse, a licensed practical nurse, a pharmacist, or an emergency responder. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a physician 168. Further, the operation 3806 illustrates accepting a dosing instruction set from a medical response unit. For example, as shown in FIGS. 1A through 1H, the interface 164 may be utilized to receive a dosing instruction set from a medical response unit 192.
  • FIG. 39 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 39 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 3902, an operation 3904, and/or an operation 3906. Further, the operation 3902 illustrates validating a dosing instruction set for performing a function. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to validate a dosing instruction set (e.g., by check the dosing instruction set against information stored in the memory 154). Further, the operation 3904 illustrates translating a dosing instruction set for performing a function into a dispensing order. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to translate a dosing instruction set into a dispensing order (e.g., by referencing the dosing instruction set to a lookup table stored in the memory 154). Further, the operation 3906 illustrates translating a medical parameter into a dispensing order. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to translate a medical parameter into a dispensing order (e.g., by referencing the medical parameter to a lookup table stored in the memory 154).
  • FIG. 40 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 40 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 4002, an operation 4004, and/or an operation 4006. Further, the operation 4002 illustrates generating a dispensing order according to the instruction set from a user. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to generate a dispensing order according to an instruction set from a user 166 stored in the memory 154. Further, the operation 4004 illustrates generating a dispensing order according to the instruction set from a health care professional. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to generate a dispensing order according to an instruction set from a physician 168 stored in the memory 154. Further, the operation 4006 illustrates generating a dispensing order according to the instruction set from a medical response unit. For example, as shown in FIGS. 1A through 1H, the processor 156 may be utilized to generate a dispensing order according to an instruction set from a medical response unit 192 stored in the memory 154.
  • FIG. 41 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 41 illustrates example embodiments where the operation 210 may include at least one additional operation. Additional operations may include an operation 4102. Further, the operation 4102 illustrates requesting a dose of the inhalable compound in accordance with a dispensing order received by a dispensing module from a reservoir. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a request from the reservoir 180 for a dose of the compound 104.
  • FIG. 42 illustrates an operational flow 4200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 42 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4210.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4200 moves to an operation 4210. Operation 4210 illustrates transmitting a dispensing order to a dispensing module. For example, as shown in FIGS. 1A through 1H, the processor 156 may transmit a dispensing order to the dispensing module 128 (e.g., to the reservoir 180).
  • FIG. 43 illustrates an operational flow 4300 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 43 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4310.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4300 moves to an operation 4310. Operation 4310 illustrates transmitting a dispensing order to a dispensing module via a wireless transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from a physician 168 via a wireless transmission received by the interface 164.
  • FIG. 44 illustrates an operational flow 4400 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 44 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4410.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4400 moves to an operation 4410. Operation 4410 illustrates transmitting a dispensing order to a dispensing module via an optical transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from a physician 168 via an optical transmission received by the interface 164.
  • FIG. 45 illustrates an operational flow 4500 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 45 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4510.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4500 moves to an operation 4510. Operation 4510 illustrates transmitting a dispensing order to a dispensing module via a wire transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from a physician 168 via an wire transmission received by the interface 164.
  • FIG. 46 illustrates an operational flow 4600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 46 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4610.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4600 moves to an operation 4610. Operation 4610 illustrates transmitting a dispensing order to a dispensing module via a mechanical transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from a physician 168 via a mechanical transmission received by the interface 164.
  • FIG. 47 illustrates an operational flow 4700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 47 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4710.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4700 moves to an operation 4710. Operation 4710 illustrates transmitting a dispensing order to a dispensing module via a radio transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from a physician 168 via a radio transmission received by the interface 164.
  • FIG. 48 illustrates an operational flow 4800 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 48 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4810.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4800 moves to an operation 4810. Operation 4810 illustrates transmitting a dispensing order to a dispensing module via a processor transmission. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may receive a dispensing order from the processor 156.
  • FIG. 49 illustrates an operational flow 4900 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 49 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 4910, an operation 4912, an operation 4914, and/or an operation 4916.
  • After a start operation, an operation 210, and an operation 220, the operational flow 4900 moves to an operation 4910. Operation 4910 illustrates controlling delivery of an inhalable compound. For example, as shown in FIGS. 1A through 1H, the demand valve 152 may be utilized to control delivery of the compound 104.
  • The operation 4912 illustrates selecting one or more delivery nozzles from a suite of nozzles. For example, as shown in FIGS. 1A through 1H, the second nozzle 150 may be selected from the suite of nozzles 148.
  • The operation 4914 illustrates directing delivery of the inhalable compound from one or more nozzles at different locations. For example, as shown in FIGS. 1A through 1H, the compound 104 may be delivered from the first nozzle 130 or the second nozzle 150.
  • The operation 4916 illustrates directing delivery of the inhalable compound by controlling a discharge direction. For example, as shown in FIGS. 1A through 1H, the direction of the subject's nose 132 may be calculated. Then, a discharge direction for the dispensing module 128 may be controlled for optimizing delivery of the compound 104.
  • FIG. 50 illustrates alternative embodiments of the example operational flow 4900 of FIG. 49. FIG. 50 illustrates example embodiments where the operation 4910 may include at least one additional operation. Additional operations may include an operation 5002, an operation 5004, and/or an operation 5006.
  • The operation 5002 illustrates directing delivery via a demand valve coupled with programmable dosing. For example, as shown in FIGS. 1A through 1H, the demand valve 152 may be operatively configured to dispense the compound 104 in accordance with a dosing schedule stored in the memory 154.
  • The operation 5004 illustrates directing delivery via a charged particle dispersion. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may dispense the compound 104 as a charged particle dispersion.
  • The operation 5006 illustrates directing delivery via a nozzle comprising variable discharge characteristics. For example, as shown in FIGS. 1A through 1H, the first nozzle 130, the second nozzle 150, or the suite of nozzles 148 may include nozzles having variable discharge characteristics, such as directional, volumetric, spray area, or other characteristics.
  • FIG. 51 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 51 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5102, an operation 5104, and/or an operation 5106.
  • The operation 5102 illustrates orienting a dispensing module to optimize respiratory receipt of an inhalable compound. For example, as shown in FIGS. 1A through 1H, the dispensing module 128 may be maintained in an optimal position for optimizing delivery of the compound 104 to the subject 102.
  • The operation 5104 illustrates maintaining a dispensing module in position to optimize respiratory receipt of an inhalable compound. For example, as shown in FIGS. 1A through 1H, the orientation of the nozzle 130 may be maintained in the direction determined for the subject's nose 132.
  • The operation 5106 illustrates determining a relative position or direction to a desired respiratory target. For example, as shown in FIGS. 1A through 1H, the direction to the subject's nose 132 may be calculated.
  • FIG. 52 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 52 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5202, an operation 5204, and/or an operation 5206.
  • The operation 5202 illustrates maintaining a position of the dispensing module via a weight. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module 128 may be maintained via a weight 136.
  • The operation 5204 illustrates maintaining a position of the dispensing module via an adhesive. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module may be maintained via an adhesive 138.
  • The operation 5206 illustrates maintaining a position of the dispensing module via a slide. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module 128 may be maintained via a slide 140.
  • FIG. 53 illustrates alternative embodiments of the example operational flow 200 of FIG. 2. FIG. 53 illustrates example embodiments where the operation 220 may include at least one additional operation. Additional operations may include an operation 5302, an operation 5304, and/or an operation 5306.
  • The operation 5302 illustrates maintaining a position of the dispensing module via a magnet. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module 128 may be maintained via a magnet 142.
  • The operation 5304 illustrates maintaining a position of the dispensing module via a fastener. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module 128 may be maintained via a fastener 144 (e.g., a button or a snap).
  • The operation 5306 illustrates maintaining a position of the dispensing module via a spring. For example, as shown in FIGS. 1A through 1H, the position of the dispensing module 128 may be maintained via a spring 146.
  • FIG. 54 illustrates an operational flow 5400 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 54 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 5410, an operation 5412, an operation 5414, and/or an operation 5416.
  • After a start operation, an operation 210, and an operation 220, the operational flow 5400 moves to an operation 5410. Operation 5410 illustrates dispensing a tracer compound in association with the inhalable compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may comprise an inhalable compound 52 and one or more tracer compounds.
  • The operation 5412 illustrates dispensing a visual tracer compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a visual tracer 54.
  • The operation 5414 illustrates dispensing an olfactory tracer compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include an olfactory tracer 56.
  • The operation 5416 illustrates dispensing a tastable tracer compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may include a tastable tracer 58.
  • FIG. 55 illustrates an operational flow 5500 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 55 illustrates an example embodiment where the example operational flow 200 of FIG. 2 may include at least one additional operation. Additional operations may include an operation 5510, an operation 5512, an operation 5514, an operation 5516, and/or an operation 5518.
  • After a start operation, an operation 210, and an operation 220, the operational flow 5500 moves to an operation 5510. Operation 5510 illustrates providing an externally observable indication of dispensing of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a visual indicator 196 for indicating dispensing of the inhalable compound.
  • The operation 5512 illustrates providing a visual indication of dispensing of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may include the visual indicator 196 for indicating dispensing of the inhalable compound.
  • The operation 5514 illustrates providing a auditory indication of dispensing of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may include an audible indicator 198.
  • The operation 5516 illustrates providing a vibrational indication of dispensing of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may include a vibrational indicator 60.
  • The operation 5518 illustrates providing an electromagnetic indication of dispensing of the inhalable compound. For example, as shown in FIGS. 1A through 1H, the collar 100 may include an electromagnetic indicator 62.
  • FIG. 56 illustrates an operational flow 5600 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. In FIG. 56 and in following figures that include various examples of operational flows, discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H, and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H. Also, although the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • After a start operation, the operational flow 5600 moves to an operation 5610. Operation 5610 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154.
  • Then, operation 5620 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position. For example, as shown in FIGS. 1A through 1H, the collar 100 may be maintained in an operable dispensing position with an adhesive 138.
  • Then, operation 5630 depicts receiving the dose of the inhalable compound for dispensing. For example, as shown in FIGS. 1A through 1H, the compound 104 may be received via the reservoir 180.
  • FIG. 57 illustrates an operational flow 5700 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. In FIG. 57 and in following figures that include various examples of operational flows, discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H, and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H. Also, although the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • After a start operation, the operational flow 5700 moves to an operation 5710. Operation 5710 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154.
  • Then, operation 5720 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position. For example, as shown in FIGS. 1A through 1H, the collar 100 may be maintained in an operable dispensing position with an adhesive 138.
  • Then, operation 5730 depicts receiving the inhalable compound. For example, as shown in FIGS. 1A through 1H, the compound 104 may be received via the reservoir 180.
  • FIG. 58 illustrates an operational flow 5800 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 58 illustrates an example embodiment where the example operational flow 5700 of FIG. 57 may include at least one additional operation. Additional operations may include an operation 5810.
  • After a start operation, an operation 5710, an operation 5720, and an operation 5730, the operational flow 5800 moves to an operation 5810. Operation 5810 illustrates containing the inhalable compound in a reservoir. For example, as shown in FIGS. 1A through 1H, the compound 104 may be contained in the reservoir 180.
  • FIG. 59 illustrates an operational flow 5900 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. In FIG. 59 and in following figures that include various examples of operational flows, discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H, and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H. Also, although the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • After a start operation, the operational flow 5900 moves to an operation 5910. Operation 5910 depicts dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154.
  • Then, operation 5920 depicts maintaining in physical association with the user a hands-free article for dispensing an inhalable compound in an operable dispensing position. For example, as shown in FIGS. 1A through 1H, the collar 100 may be maintained in an operable dispensing position with an adhesive 138.
  • Then, operation 5930 depicts supporting a hands-free aerosol delivery system on the body of a mammal. For example, as shown in FIGS. 1A through 1H, the collar 100 may be supported on the body of the subject 102.
  • FIG. 60 illustrates an operational flow 6000 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. In FIG. 60 and in following figures that include various examples of operational flows, discussion and explanation may be provided with respect to the above-described examples of FIGS. 1A through 1H, and/or with respect to other examples and contexts. However, it should be understood that the operational flows may be executed in a number of other environments and contexts, and/or in modified versions of FIGS. 1A through 1H. Also, although the various operational flows are presented in the sequence(s) illustrated, it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently.
  • After a start operation, the operational flow 6000 moves to an operation 6010. Operation 6010 depicts detecting a medical condition parameter of a mammal according to a medical condition parameter request. For example, as shown in FIGS. 1A through 1H, the collar 100 may utilize a sensor module 170 to detect a medical condition parameter for the subject 102 according to a request from a physician 168. The request may be received via the interface 164 and then transferred to the sensor module 170 via the processor 156.
  • Then, operation 6020 depicts maintaining in physical association with a user a hands-free article for dispensing an inhalable compound in an operable dispensing position. For example, as shown in FIGS. 1A through 1H, the collar 100 may be maintained in an operable dispensing position with an adhesive 138.
  • Then, operation 6030 depicts dispensing for inhalation by the user a dose of an inhalable compound according to a dosing instruction set. For example, as shown in FIGS. 1A through 1H, the collar 100 may dispense a dose 158 of a compound 104 according to a dosing instruction set stored in a memory 154.
  • FIG. 61 illustrates an operational flow 6100 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 61 illustrates an example embodiment where the example operational flow 6000 of FIG. 60 may include at least one additional operation. Additional operations may include an operation 6110.
  • After a start operation, an operation 6010, an operation 6020, and an operation 6030, the operational flow 6100 moves to an operation 6110. Operation 6110 illustrates recording the detected medical condition parameter data. It will be appreciated that a sleep state may be included as a medical condition. For example, as shown in FIGS. 1A through 1H, the detected medical condition data may be recorded to the memory 154.
  • FIG. 62 illustrates an operational flow 6200 representing example operations related to maintaining a hands-free article for dispensing an inhalable compound according to a dosing instruction set, where the hands-free article is maintained in an operable dispensing position. FIG. 62 illustrates an example embodiment where the example operational flow 6000 of FIG. 60 may include at least one additional operation. Additional operations may include an operation 6210, an operation 6212, and/or an operation 6214.
  • After a start operation, an operation 6010, an operation 6020, and an operation 6030, the operational flow 6200 moves to an operation 6210. Operation 6210 illustrates transferring the detected medical condition parameter data. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transferred to a flash drive 64.
  • The operation 6212 illustrates transferring the detected medical condition parameter data to a flash drive. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transferred to a flash drive 64.
  • The operation 6214 illustrates transferring the detected medical condition parameter data to a hard drive. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transferred to a hard drive 66.
  • FIG. 63 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 63 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6302.
  • The operation 6302 illustrates downloading the detected medical condition parameter data to a RAM. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be downloaded to a random access memory (RAM) 68. In an embodiment, the detected medical condition data may be transmitted to a processor (e.g., processor 156). In an embodiment, the detected medical condition may be transmitted to an external site (e.g., the medical response unit 192).
  • FIG. 64 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 64 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6402, and/or an operation 6404.
  • The operation 6402 illustrates transmitting the detected medical condition parameter to a dispensing module. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128. Further, the operation 6404 illustrates transmitting the detected medical condition parameter to a dispensing module via a wireless transmission. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 wirelessly.
  • FIG. 65 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 65 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6502. Further, the operation 6502 illustrates transmitting the detected medical condition parameter to a dispensing module via a wire transmission. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a wired connection.
  • FIG. 66 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 66 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6602. Further, the operation 6602 illustrates transmitting the detected medical condition parameter to a dispensing module via a radio transmission. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a radio signal.
  • FIG. 67 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 67 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6702. Further, the operation 6702 illustrates transmitting the detected medical condition parameter to a dispensing module via an optical transmission. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via an optical transmission.
  • FIG. 68 illustrates alternative embodiments of the example operational flow 6200 of FIG. 62. FIG. 68 illustrates example embodiments where the operation 6210 may include at least one additional operation. Additional operations may include an operation 6802. Further, the operation 6802 illustrates transmitting the detected medical condition parameter to a dispensing module via a mechanical transmission. For example, as shown in FIGS. 1A through 1H, the detected medical condition data stored in the memory 154 may be transmitted to the dispensing module 128 via a mechanical transmission.
  • In an embodiment, the collar 100 may include a metered dose inhaler for delivering a metered dosage of an inhaled bronchodilator when the sensor module 170 detects a condition (e.g., an asthmatic incident including narrowing of the subject's airways) or a symptom indicative of a condition (e.g., narrowing of the subject's airways, wheezing, or decreased exhalation volume). In an embodiment, the sensor module 170 transmits the detected condition or symptom to the processor 156. The processor 156 utilizes information stored in the memory 154 to determine the most appropriate course of action for the detected condition/symptom. For example, the memory 154 may include instructions for dispensing (e.g., via the dispensing module 128) a metered dose of the inhaled bronchodilator (which is stored in reservoir 180) when the incident is detected. In an embodiment, the memory 154 includes instructions for subsequent administration of the bronchodilator at some time after the initial condition/symptom is detected (e.g., in the case of a late-phase allergic reaction). The memory 154 may also include instructions for activating a visual indicator 196 so that the subject 102 or an observer may be alerted to the subject's condition.
  • Those having skill in the art will recognize that the state of the art has progressed to the point where there is little distinction left between hardware, software, and/or firmware implementations of aspects of systems; the use of hardware, software, and/or firmware is generally (but not always, in that in certain contexts the choice between hardware and software can become significant) a design choice representing cost vs. efficiency tradeoffs. Those having skill in the art will appreciate that there are various vehicles by which processes and/or systems and/or other technologies described herein can be effected (e.g., hardware, software, and/or firmware), and that the preferred vehicle will vary with the context in which the processes and/or systems and/or other technologies are deployed. For example, if an implementer determines that speed and accuracy are paramount, the implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware. Hence, there are several possible vehicles by which the processes and/or devices and/or other technologies described herein may be effected, none of which is inherently superior to the other in that any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary. Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
  • In some implementations described herein, logic and similar implementations may include software or other control structures. Electronic circuitry, for example, may have one or more paths of electrical current constructed and arranged to implement various functions as described herein. In some implementations, one or more media may be configured to bear a device-detectable implementation when such media hold or transmit device detectable instructions operable to perform as described herein. In some variants, for example, implementations may include an update or modification of existing software or firmware, or of gate arrays or programmable hardware, such as by performing a reception of or a transmission of one or more instructions in relation to one or more operations described herein. Alternatively or additionally, in some variants, an implementation may include special-purpose hardware, software, firmware components, and/or general-purpose components executing or otherwise invoking special-purpose components. Specifications or other implementations may be transmitted by one or more instances of tangible transmission media as described herein, optionally by packet transmission or otherwise by passing through distributed media at various times.
  • Alternatively or additionally, implementations may include executing a special-purpose instruction sequence or invoking circuitry for enabling, triggering, coordinating, requesting, or otherwise causing one or more occurrences of virtually any functional operations described herein. In some variants, operational or other logical descriptions herein may be expressed as source code and compiled or otherwise invoked as an executable instruction sequence. In some contexts, for example, implementations may be provided, in whole or in part, by source code, such as C++, or other code sequences. In other implementations, source or other code implementation, using commercially available and/or techniques in the art, may be compiled//implemented/translated/converted into a high-level descriptor language (e.g., initially implementing described technologies in C or C++ programming language and thereafter converting the programming language implementation into a logic-synthesizable language implementation, a hardware description language implementation, a hardware design simulation implementation, and/or other such similar mode(s) of expression). For example, some or all of a logical expression (e.g., computer programming language implementation) may be manifested as a Verilog-type hardware description (e.g., via Hardware Description Language (HDL) and/or Very High Speed Integrated Circuit Hardware Descriptor Language (VHDL)) or other circuitry model which may then be used to create a physical implementation having hardware (e.g., an Application Specific Integrated Circuit). Those skilled in the art will recognize how to obtain, configure, and optimize suitable transmission or computational elements, material supplies, actuators, or other structures in light of these teachings.
  • The foregoing detailed description has set forth various embodiments of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one embodiment, several portions of the subject matter described herein may be implemented via Application Specific Integrated Circuits (ASICs), Field Programmable Gate Arrays (FPGAs), digital signal processors (DSPs), or other integrated formats. However, those skilled in the art will recognize that some aspects of the embodiments disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution. Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link (e.g., transmitter, receiver, transmission logic, reception logic, etc.), etc.).
  • In a general sense, those skilled in the art will recognize that the various embodiments described herein can be implemented, individually and/or collectively, by various types of electro-mechanical systems having a wide range of electrical components such as hardware, software, firmware, and/or virtually any combination thereof; and a wide range of components that may impart mechanical force or motion such as rigid bodies, spring or torsional bodies, hydraulics, electromagnetically actuated devices, and/or virtually any combination thereof. Consequently, as used herein “electro-mechanical system” includes, but is not limited to, electrical circuitry operably coupled with a transducer (e.g., an actuator, a motor, a piezoelectric crystal, a Micro Electro Mechanical System (MEMS), etc.), electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of memory (e.g., random access, flash, read only, etc.)), electrical circuitry forming a communications device (e.g., a modem, communications switch, optical-electrical equipment, etc.), and/or any non-electrical analog thereto, such as optical or other analogs. Those skilled in the art will also appreciate that examples of electro-mechanical systems include but are not limited to a variety of consumer electronics systems, medical devices, as well as other systems such as motorized transport systems, factory automation systems, security systems, and/or communication/computing systems. Those skilled in the art will recognize that electro-mechanical as used herein is not necessarily limited to a system that has both electrical and mechanical actuation except as context may dictate otherwise.
  • In a general sense, those skilled in the art will recognize that the various aspects described herein which can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, and/or any combination thereof can be viewed as being composed of various types of “electrical circuitry.” Consequently, as used herein “electrical circuitry” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of memory (e.g., random access, flash, read only, etc.)), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, optical-electrical equipment, etc.). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.
  • Those skilled in the art will recognize that at least a portion of the devices and/or processes described herein can be integrated into a data processing system. Those having skill in the art will recognize that a data processing system generally includes one or more of a system unit housing, a video display device, memory such as volatile or non-volatile memory, processors such as microprocessors or digital signal processors, computational entities such as operating systems, drivers, graphical user interfaces, and applications programs, one or more interaction devices (e.g., a touch pad, a touch screen, an antenna, etc.), and/or control systems including feedback loops and control motors (e.g., feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities). A data processing system may be implemented utilizing suitable commercially available components, such as those typically found in data computing/communication and/or network computing/communication systems.
  • All of the above U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in any Application Data Sheet, are incorporated herein by reference, to the extent not inconsistent herewith.
  • One skilled in the art will recognize that the herein described components (e.g., operations), devices, objects, and the discussion accompanying them are used as examples for the sake of conceptual clarity and that various configuration modifications are contemplated. Consequently, as used herein, the specific exemplars set forth and the accompanying discussion are intended to be representative of their more general classes. In general, use of any specific exemplar is intended to be representative of its class, and the non-inclusion of specific components (e.g., operations), devices, and objects should not be taken limiting.
  • Although user 166 is shown/described herein as a single illustrated figure, those skilled in the art will appreciate that user 166 may be representative of a human user, a robotic user (e.g., computational entity), and/or substantially any combination thereof (e.g., a user may be assisted by one or more robotic agents) unless context dictates otherwise. Those skilled in the art will appreciate that, in general, the same may be said of “sender” and/or other entity-oriented terms as such terms are used herein unless context dictates otherwise.
  • With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations are not expressly set forth herein for sake of clarity.
  • The herein described subject matter sometimes illustrates different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures may be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable,” to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components.
  • In some instances, one or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that such terms (e.g. “configured to”) can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.
  • White particular aspects of the present subject matter described herein have been shown and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from the subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of the subject matter described herein. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”
  • With respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flows are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.

Claims (20)

1. A method for administering an inhalable compound, comprising:
dispensing for inhalation by a user a dose of an inhalable compound according to a dosing instruction set;
maintaining in physical association with the user a hands-free article for dispensing the inhalable compound in an operable dispensing position; and
receiving the dose of the inhalable compound for dispensing.
2. The method of claim 1, wherein receiving the dose of the inhalable compound for dispensing comprises:
receiving a dose of a pharmaceutical compound for dispensing.
3. The method of claim 1, wherein receiving the dose of the inhalable compound for dispensing comprises:
receiving a dose of a therapeutic compound for dispensing.
4. The method of claim 1, wherein receiving the dose of the inhalable compound for dispensing comprises:
receiving a dose of a homeopathic compound for dispensing.
5. The method of claim 1, wherein receiving the dose of the inhalable compound for dispensing comprises:
receiving a dose of a nutraceutical compound for dispensing.
6. The method of claim 3, further comprising:
receiving a dosing instruction set.
7. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a wireless transmission.
8. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a processor.
9. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a connectable device containing digital instructions or data.
10. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a wire transmission.
11. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via an optical transmission.
12. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a radio transmission.
13. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set via a mechanical transmission.
14. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from a user.
15. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from a health care provider.
16. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from a pharmacist.
17. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from at least one of a parent or a guardian.
18. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from at least one of a pet owner, an animal researcher, or an animal owner.
19. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from a veterinarian health care provider.
20. The method of claim 6, wherein receiving a dosing instruction set comprises:
receiving a dosing instruction set from a medical response unit.
US12/455,666 2008-12-30 2009-06-04 Method for administering an inhalable compound Abandoned US20100163039A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/455,666 US20100163039A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,667 US9750903B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,676 US20100163029A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,681 US20100163020A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,672 US9724483B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US12/317,934 US20100163024A1 (en) 2008-12-30 2008-12-30 Methods and systems for presenting an inhalation experience
US12/319,143 US20100163025A1 (en) 2008-12-30 2008-12-31 Methods and systems for presenting an inhalation experience
US12/378,284 US20100163033A1 (en) 2008-12-30 2009-02-12 Methods and systems for presenting an inhalation experience
US12/378,485 US8725529B2 (en) 2008-12-30 2009-02-13 Methods and systems for presenting an inhalation experience
US12/380,013 US20100166613A1 (en) 2008-12-30 2009-02-20 Methods and systems for presenting an inhalation experience
US12/380,108 US20100163034A1 (en) 2008-12-30 2009-02-23 Methods and systems for presenting an inhalation experience
US12/380,587 US20100163027A1 (en) 2008-12-30 2009-02-27 Methods and systems for presenting an inhalation experience
US12/380,679 US20100168525A1 (en) 2008-12-30 2009-03-02 Methods and systems for presenting an inhalation experience
US12/383,509 US8706518B2 (en) 2008-12-30 2009-03-25 Methods and systems for presenting an inhalation experience
US12/383,819 US20100168602A1 (en) 2008-12-30 2009-03-26 Methods and systems for presenting an inhalation experience
US12/384,104 US20100163036A1 (en) 2008-12-30 2009-03-31 Methods and systems for presenting an inhalation experience
US12/384,203 US8694330B2 (en) 2008-12-30 2009-04-01 Methods and systems for presenting an inhalation experience
US12/386,574 US20100168529A1 (en) 2008-12-30 2009-04-20 Methods and systems for presenting an inhalation experience
US12/386,669 US8738395B2 (en) 2008-12-30 2009-04-21 Methods and systems for presenting an inhalation experience
US12/387,057 US8712794B2 (en) 2008-12-30 2009-04-27 Methods and systems for presenting an inhalation experience
US12/387,151 US20100169259A1 (en) 2008-12-30 2009-04-28 Methods and systems for presenting an inhalation experience
US12/387,321 US20100163038A1 (en) 2008-12-30 2009-04-30 Methods and systems for presenting an inhalation experience
US12/387,472 US20100169260A1 (en) 2008-12-30 2009-05-01 Methods and systems for presenting an inhalation experience
US12/455,676 US20100163029A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,681 US20100163020A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,672 US9724483B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,667 US9750903B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,666 US20100163039A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/317,934 Continuation-In-Part US20100163024A1 (en) 2008-12-30 2008-12-30 Methods and systems for presenting an inhalation experience

Publications (1)

Publication Number Publication Date
US20100163039A1 true US20100163039A1 (en) 2010-07-01

Family

ID=42595872

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/455,667 Expired - Fee Related US9750903B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,672 Expired - Fee Related US9724483B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,666 Abandoned US20100163039A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,681 Abandoned US20100163020A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,676 Abandoned US20100163029A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US12/455,667 Expired - Fee Related US9750903B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,672 Expired - Fee Related US9724483B2 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/455,681 Abandoned US20100163020A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound
US12/455,676 Abandoned US20100163029A1 (en) 2008-12-30 2009-06-04 Method for administering an inhalable compound

Country Status (1)

Country Link
US (5) US9750903B2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
JP6397493B2 (en) 2013-07-11 2018-09-26 アレックザ ファーマシューティカルズ， インコーポレイテッド Nicotine salt with meta-salicylic acid
US10758700B2 (en) * 2013-09-30 2020-09-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Home-based heliox system with carbon dioxide removal
US10019555B2 (en) 2013-10-19 2018-07-10 Cohero Health, Inc. Interactive respiratory device usage tracking system
US11424017B2 (en) 2013-10-19 2022-08-23 Aptargroup, Inc. Respiratory system and method that monitors medication flow
US20160158471A1 (en) * 2014-12-05 2016-06-09 Dance Biopharm, Inc. Integration of glucose data to adjust inhaled insulin dose
US10799660B2 (en) * 2015-09-15 2020-10-13 Peter Daniel Klurfeld Wearable multifunctional inhaler, vaporizer watch
WO2019104068A1 (en) * 2017-11-21 2019-05-31 Boston Scientific Scimed, Inc Interactive wearable and e-tattoo combinations
US11202881B2 (en) 2018-06-06 2021-12-21 Chaddi Rife Chest-supported nebulizer apparatus
US11638722B2 (en) 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
US11278602B2 (en) 2020-03-25 2022-03-22 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021191496A1 (en) * 2020-03-25 2021-09-30 Therapeutica Borealis Oy Medicine for covid-19 and treatment
US11045622B1 (en) * 2020-06-12 2021-06-29 James M. Johnson Shoulder-worn diffuser
US11701479B1 (en) * 2022-02-01 2023-07-18 Green Sky Creations LLC Systems, devices, and methods for administering cannabinoid mixtures

Citations (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4068624A (en) * 1976-05-21 1978-01-17 Bio-Pet Research Company Refillable permanent collar for animals
US4265236A (en) * 1980-03-31 1981-05-05 Pacella Angelo M Portable inhalator device
US4652261A (en) * 1984-06-22 1987-03-24 Regents Of The University Of Minnesota Drug-injection animal capture collar
US4784162A (en) * 1986-09-23 1988-11-15 Advanced Medical Technologies Portable, multi-channel, physiological data monitoring system
US5071704A (en) * 1990-06-13 1991-12-10 Fischel Ghodsian Fariba Device for controlled release of vapors and scents
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route
US5458853A (en) * 1989-04-03 1995-10-17 Lion Analytics Pty. Ltd. Breath analysis device
US5487378A (en) * 1990-12-17 1996-01-30 Minnesota Mining And Manufacturing Company Inhaler
US5546943A (en) * 1994-12-09 1996-08-20 Gould; Duncan K. Stimulating a beneficial human response by using visualization of medical scan data to achieve psychoneuroimmunological virtual reality
US5610674A (en) * 1995-06-19 1997-03-11 Martin; David A. Precision fragrance dispenser apparatus
US5709863A (en) * 1995-02-03 1998-01-20 Pageat; Patrick Properties of cats' facial pheromones
US5725472A (en) * 1995-12-18 1998-03-10 Weathers; Lawrence R. Psychotherapy apparatus and method for the inputting and shaping new emotional physiological and cognitive response patterns in patients
US5842467A (en) * 1996-06-19 1998-12-01 Greco; Michael Metered dose inhaler and ambulatory manual breathing unit combination
US5954641A (en) * 1997-09-08 1999-09-21 Informedix, Inc. Method, apparatus and operating system for managing the administration of medication and medical treatment regimens
US6026807A (en) * 1998-02-27 2000-02-22 Diemolding Corporation Metered dose inhaler cloud chamber
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6168562B1 (en) * 1998-03-31 2001-01-02 Scientific Learning Corporation Method and apparatus for dynamically tailoring biochemical based therapy programs in human
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6223744B1 (en) * 1999-03-16 2001-05-01 Multi-Vet Ltd. Wearable aerosol delivery apparatus
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6280383B1 (en) * 1993-03-01 2001-08-28 Fonar Corporation Magnetic resonance imaging
US6397837B1 (en) * 1999-07-22 2002-06-04 Martin W. Ferris Inhaler assistive device
US20020084996A1 (en) * 2000-04-28 2002-07-04 Texas Tech University Development of stereoscopic-haptic virtual environments
US6425764B1 (en) * 1997-06-09 2002-07-30 Ralph J. Lamson Virtual reality immersion therapy for treating psychological, psychiatric, medical, educational and self-help problems
US6443153B1 (en) * 1997-09-30 2002-09-03 Euromaski Oy Arrangement in protective device
US6513523B1 (en) * 2000-11-08 2003-02-04 Mallinckrodt Inc. Wearable belt incorporating gas storage vessel comprising a polymeric container system for pressurized fluids
US20030114475A1 (en) * 2001-10-31 2003-06-19 Addiction Therapies, Inc. Methods for the treatment of addiction
US6585519B1 (en) * 1998-01-23 2003-07-01 Scientific Learning Corp. Uniform motivation for multiple computer-assisted training systems
US6609068B2 (en) * 2000-02-22 2003-08-19 Dow Global Technologies Inc. Personal computer breath analyzer for health-related behavior modification and method
US6684880B2 (en) * 2001-12-04 2004-02-03 Hewlett-Packard Development Company, L.P. Applicator for dispensing bioactive compositions and methods for using the same
US20040116784A1 (en) * 2002-12-13 2004-06-17 Intercure Ltd. Apparatus and method for beneficial modification of biorhythmic activity
US6780171B2 (en) * 2002-04-02 2004-08-24 Becton, Dickinson And Company Intradermal delivery device
US20040254501A1 (en) * 2000-08-11 2004-12-16 Mault James R. Achieving a relaxed state
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
US6889687B1 (en) * 1999-11-02 2005-05-10 Shl Medical Ab Inhalator with aerosolizing unit
US20050115561A1 (en) * 2003-08-18 2005-06-02 Stahmann Jeffrey E. Patient monitoring, diagnosis, and/or therapy systems and methods
US20050220843A1 (en) * 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
US6978212B1 (en) * 1999-11-01 2005-12-20 Smiths Detection Inc. System for portable sensing
US6981502B2 (en) * 2004-04-01 2006-01-03 Numask, Inc. Respiratory mask having intraoral mouthpiece with large sealing area and multiple sealing configuration
US20060031099A1 (en) * 2003-06-10 2006-02-09 Vitello Christopher J System and methods for administering bioactive compositions
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US20070068515A1 (en) * 2005-09-23 2007-03-29 Natalie Churchill Apparatus for administration of aromatherapy on a massage table or chair
US20070068514A1 (en) * 2001-09-28 2007-03-29 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US20080014566A1 (en) * 2006-07-12 2008-01-17 Stephen Chapman Virtual human interaction system
US20080038701A1 (en) * 2006-08-08 2008-02-14 Charles Booth Training system and method
US7353065B2 (en) * 2004-09-14 2008-04-01 Neuropace, Inc. Responsive therapy for psychiatric disorders
US20080087279A1 (en) * 2006-10-11 2008-04-17 Tieck Catharine Laureen Johnso Metered dose inhaler
US7373377B2 (en) * 2002-10-16 2008-05-13 Barbaro Technologies Interactive virtual thematic environment
US7383837B2 (en) * 2000-08-29 2008-06-10 Smithkline Beecham Corporation Inhalation device
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US7427417B2 (en) * 2004-03-19 2008-09-23 Sequim Lavender Company, Llc Aromatherapy delivery system
US20080230057A1 (en) * 2005-05-20 2008-09-25 Garth Campbell Sutherland Reminder For a Medicament Inhaler
US7447541B2 (en) * 2004-06-30 2008-11-04 Instrumentarium Corporation Monitoring subcortical responsiveness of a patient
US20080318913A1 (en) * 2005-02-11 2008-12-25 Justian Craig Fox Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
US20090306741A1 (en) * 2006-10-26 2009-12-10 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
US7720696B1 (en) * 2007-02-26 2010-05-18 Mk3Sd, Ltd Computerized system for tracking health conditions of users
US20110226242A1 (en) * 2008-08-25 2011-09-22 Koninklijke Philips Electronics N.V. Respiratory drug delivery apparatus which provides audio instructions
US8068983B2 (en) * 2008-06-11 2011-11-29 The Boeing Company Virtual environment systems and methods

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167658D1 (en) 1980-12-12 1985-01-17 Combi Co Inhaler
JP3575894B2 (en) 1995-12-11 2004-10-13 三菱プレシジョン株式会社 Relative angle detection device and virtual reality providing device
US5807114A (en) 1996-03-27 1998-09-15 Emory University And Georgia Tech Research Corporation System for treating patients with anxiety disorders
US5949522A (en) 1996-07-03 1999-09-07 Manne; Joseph S. Multimedia linked scent delivery system
KR100454157B1 (en) 1997-05-07 2004-10-26 컴퓨메딕스 슬립 피티와이. 리미티드 Apparatus for controlling gas delivery to patient
JP2917973B2 (en) 1997-06-23 1999-07-12 日本電気株式会社 Simulated bodily sensation device
US20010034023A1 (en) 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
US6135928A (en) 1999-08-20 2000-10-24 Butterfield; Anthony Virtual reality equipment
US6554707B1 (en) 1999-09-24 2003-04-29 Nokia Corporation Interactive voice, wireless game system using predictive command input
US7156809B2 (en) 1999-12-17 2007-01-02 Q-Tec Systems Llc Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US6561415B2 (en) 2000-04-27 2003-05-13 Katherine Grant Calorie management system
US20030036683A1 (en) * 2000-05-01 2003-02-20 Kehr Bruce A. Method, system and computer program product for internet-enabled, patient monitoring system
IL157580A0 (en) 2001-03-20 2004-03-28 Glaxo Group Ltd Inhalation drug combination
EP1420683A4 (en) 2001-06-15 2009-08-05 Univ Pennsylvania Functional brain imaging for detecting and assessing deception and concealed recognition, and cognitive/emotional response to information
US6702767B1 (en) 2001-09-25 2004-03-09 Nelson R. Douglas Multisensory stimulation system and method
AU2002343194A1 (en) 2001-11-20 2003-06-10 Avi Peled System and method for diagnosis of mental disorders
JP2003159332A (en) 2001-11-27 2003-06-03 Omron Corp Nebulizer, server, nebulizer system, method for medicine distinction in nebulizer, method for detecting medicine quantity, method for managing information in nebulizer system, program for managing nebulizer information, and recording medium for recording program
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US20030221687A1 (en) 2002-05-09 2003-12-04 William Kaigler Medication and compliance management system and method
US7305600B2 (en) * 2003-08-29 2007-12-04 International Business Machines Corporation Partial good integrated circuit and method of testing same
US20050228691A1 (en) 2004-04-07 2005-10-13 Michael Paparo Automated wellness system managing personalized fitness programs
US20050234742A1 (en) 2004-04-08 2005-10-20 Hodgdon Darren W Incentive based health care insurance program
WO2005118036A2 (en) 2004-06-01 2005-12-15 Yashwant Gilbert Chathampally Systems and methods for the administration of drugs and medications
US20060085230A1 (en) 2004-07-15 2006-04-20 Brill Joel V Methods and systems for healthcare assessment
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Biosynchronous transdermal drug delivery
WO2006048417A1 (en) 2004-11-02 2006-05-11 Novo Nordisk A/S Inhalation therapy compliance tracking system and apparatus
KR20060064885A (en) 2004-12-09 2006-06-14 삼성전자주식회사 Device, system and method for providing health management service
US20070016265A1 (en) 2005-02-09 2007-01-18 Alfred E. Mann Institute For Biomedical Engineering At The University Of S. California Method and system for training adaptive control of limb movement
WO2006090371A2 (en) 2005-02-22 2006-08-31 Health-Smart Limited Methods and systems for physiological and psycho-physiological monitoring and uses thereof
US7540172B2 (en) 2005-05-19 2009-06-02 Chamilia, Llc Apparatus for adjustable bead retention on bracelets and necklaces
US8926991B2 (en) 2005-06-14 2015-01-06 Botulinum Toxin Research Associates, Inc. Botulinum toxin and the treatment of primary disorders of mood and affect
US7798144B2 (en) 2005-07-29 2010-09-21 Resmed Limited Life style flow generator and mask system
US7575768B2 (en) 2005-09-07 2009-08-18 Brandeis University Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US7711583B2 (en) 2005-10-05 2010-05-04 Medco Health Solutions, Inc. System and method for clinical strategy for therapeutic pharmacies
US20070124175A1 (en) 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware. Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20090046140A1 (en) 2005-12-06 2009-02-19 Microvision, Inc. Mobile Virtual Reality Projector
EP1959880B1 (en) * 2005-12-06 2012-09-26 Tytex A/S Garment for abdominal compression
US20070255115A1 (en) 2006-04-27 2007-11-01 Anglin Richard L Jr Remote diagnostic & treatment system
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US8326545B2 (en) 2006-10-18 2012-12-04 General Electric Company System and method for displaying a pharmacokinetic and pharmacodynamic drug model
CA2673644C (en) 2006-12-27 2016-02-09 Case Western Reserve University Situated simulation for training, education, and therapy
US20080281639A1 (en) 2007-05-09 2008-11-13 Quinn Peter C Real-time evidence- and guideline-based recommendation method and system for patient care
WO2008151019A1 (en) 2007-05-30 2008-12-11 University Of Florida Research Foundation, Inc. Extended release of bioactive molecules from silicone hydrogels
JP5813323B2 (en) 2007-10-24 2015-11-17 マンカインド コーポレイション Active drug delivery method

Patent Citations (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4068624A (en) * 1976-05-21 1978-01-17 Bio-Pet Research Company Refillable permanent collar for animals
US4265236A (en) * 1980-03-31 1981-05-05 Pacella Angelo M Portable inhalator device
US4652261A (en) * 1984-06-22 1987-03-24 Regents Of The University Of Minnesota Drug-injection animal capture collar
US4784162A (en) * 1986-09-23 1988-11-15 Advanced Medical Technologies Portable, multi-channel, physiological data monitoring system
US5458853A (en) * 1989-04-03 1995-10-17 Lion Analytics Pty. Ltd. Breath analysis device
US5071704A (en) * 1990-06-13 1991-12-10 Fischel Ghodsian Fariba Device for controlled release of vapors and scents
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route
US5487378A (en) * 1990-12-17 1996-01-30 Minnesota Mining And Manufacturing Company Inhaler
US6280383B1 (en) * 1993-03-01 2001-08-28 Fonar Corporation Magnetic resonance imaging
US5546943A (en) * 1994-12-09 1996-08-20 Gould; Duncan K. Stimulating a beneficial human response by using visualization of medical scan data to achieve psychoneuroimmunological virtual reality
US5709863A (en) * 1995-02-03 1998-01-20 Pageat; Patrick Properties of cats' facial pheromones
US5610674A (en) * 1995-06-19 1997-03-11 Martin; David A. Precision fragrance dispenser apparatus
US5725472A (en) * 1995-12-18 1998-03-10 Weathers; Lawrence R. Psychotherapy apparatus and method for the inputting and shaping new emotional physiological and cognitive response patterns in patients
US5842467A (en) * 1996-06-19 1998-12-01 Greco; Michael Metered dose inhaler and ambulatory manual breathing unit combination
US6425764B1 (en) * 1997-06-09 2002-07-30 Ralph J. Lamson Virtual reality immersion therapy for treating psychological, psychiatric, medical, educational and self-help problems
US5954641A (en) * 1997-09-08 1999-09-21 Informedix, Inc. Method, apparatus and operating system for managing the administration of medication and medical treatment regimens
US6443153B1 (en) * 1997-09-30 2002-09-03 Euromaski Oy Arrangement in protective device
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6585519B1 (en) * 1998-01-23 2003-07-01 Scientific Learning Corp. Uniform motivation for multiple computer-assisted training systems
US6026807A (en) * 1998-02-27 2000-02-22 Diemolding Corporation Metered dose inhaler cloud chamber
US6168562B1 (en) * 1998-03-31 2001-01-02 Scientific Learning Corporation Method and apparatus for dynamically tailoring biochemical based therapy programs in human
US6223744B1 (en) * 1999-03-16 2001-05-01 Multi-Vet Ltd. Wearable aerosol delivery apparatus
US6397837B1 (en) * 1999-07-22 2002-06-04 Martin W. Ferris Inhaler assistive device
US6978212B1 (en) * 1999-11-01 2005-12-20 Smiths Detection Inc. System for portable sensing
US6889687B1 (en) * 1999-11-02 2005-05-10 Shl Medical Ab Inhalator with aerosolizing unit
US6609068B2 (en) * 2000-02-22 2003-08-19 Dow Global Technologies Inc. Personal computer breath analyzer for health-related behavior modification and method
US20020084996A1 (en) * 2000-04-28 2002-07-04 Texas Tech University Development of stereoscopic-haptic virtual environments
US20040254501A1 (en) * 2000-08-11 2004-12-16 Mault James R. Achieving a relaxed state
US7383837B2 (en) * 2000-08-29 2008-06-10 Smithkline Beecham Corporation Inhalation device
US6513523B1 (en) * 2000-11-08 2003-02-04 Mallinckrodt Inc. Wearable belt incorporating gas storage vessel comprising a polymeric container system for pressurized fluids
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US20070068514A1 (en) * 2001-09-28 2007-03-29 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US20030114475A1 (en) * 2001-10-31 2003-06-19 Addiction Therapies, Inc. Methods for the treatment of addiction
US6684880B2 (en) * 2001-12-04 2004-02-03 Hewlett-Packard Development Company, L.P. Applicator for dispensing bioactive compositions and methods for using the same
US7198044B2 (en) * 2001-12-04 2007-04-03 Hewlett-Packard Development Company, L.P. Applicator for dispensing bioactive compositions and methods for using the same
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
US6780171B2 (en) * 2002-04-02 2004-08-24 Becton, Dickinson And Company Intradermal delivery device
US7373377B2 (en) * 2002-10-16 2008-05-13 Barbaro Technologies Interactive virtual thematic environment
US20040116784A1 (en) * 2002-12-13 2004-06-17 Intercure Ltd. Apparatus and method for beneficial modification of biorhythmic activity
US20060031099A1 (en) * 2003-06-10 2006-02-09 Vitello Christopher J System and methods for administering bioactive compositions
US20050115561A1 (en) * 2003-08-18 2005-06-02 Stahmann Jeffrey E. Patient monitoring, diagnosis, and/or therapy systems and methods
US7427417B2 (en) * 2004-03-19 2008-09-23 Sequim Lavender Company, Llc Aromatherapy delivery system
US6981502B2 (en) * 2004-04-01 2006-01-03 Numask, Inc. Respiratory mask having intraoral mouthpiece with large sealing area and multiple sealing configuration
US20050220843A1 (en) * 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
US7447541B2 (en) * 2004-06-30 2008-11-04 Instrumentarium Corporation Monitoring subcortical responsiveness of a patient
US7353065B2 (en) * 2004-09-14 2008-04-01 Neuropace, Inc. Responsive therapy for psychiatric disorders
US20080318913A1 (en) * 2005-02-11 2008-12-25 Justian Craig Fox Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US20080230057A1 (en) * 2005-05-20 2008-09-25 Garth Campbell Sutherland Reminder For a Medicament Inhaler
US20070068515A1 (en) * 2005-09-23 2007-03-29 Natalie Churchill Apparatus for administration of aromatherapy on a massage table or chair
US20080014566A1 (en) * 2006-07-12 2008-01-17 Stephen Chapman Virtual human interaction system
US20080038701A1 (en) * 2006-08-08 2008-02-14 Charles Booth Training system and method
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US20080087279A1 (en) * 2006-10-11 2008-04-17 Tieck Catharine Laureen Johnso Metered dose inhaler
US20090306741A1 (en) * 2006-10-26 2009-12-10 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
US7720696B1 (en) * 2007-02-26 2010-05-18 Mk3Sd, Ltd Computerized system for tracking health conditions of users
US8068983B2 (en) * 2008-06-11 2011-11-29 The Boeing Company Virtual environment systems and methods
US20110226242A1 (en) * 2008-08-25 2011-09-22 Koninklijke Philips Electronics N.V. Respiratory drug delivery apparatus which provides audio instructions

Also Published As

Publication number Publication date
US20100163020A1 (en) 2010-07-01
US9750903B2 (en) 2017-09-05
US9724483B2 (en) 2017-08-08
US20100163029A1 (en) 2010-07-01
US20100163041A1 (en) 2010-07-01
US20100163040A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
US9750903B2 (en) Method for administering an inhalable compound
JP7072554B2 (en) Droplet delivery device for supplying fluid to the lung system and how to use it
US20220126036A1 (en) Systems and methods of aerosol delivery with airflow regulation
EP2914320B1 (en) Systems for administering pulmonary medication
Ibrahim et al. Inhalation drug delivery devices: technology update
US20230330362A1 (en) Dry powder delivery device and methods of use
US8534277B2 (en) Device, system and method for targeting aerosolized particles to a specific area of the lungs
US20160325058A1 (en) Systems and methods for managing pulmonary medication delivery
Cazzola et al. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease
JP3213587U (en) Nebulizer for infants and patients with respiratory failure
EP3950028A1 (en) Systems and methods of aerosol delivery with airflow regulation
JP2004528150A (en) Drug dispenser
JP2002504833A (en) Device for administering insulin at a controlled dose by controlling the total inhalation volume
JP2003516199A (en) Drug dispenser
JPH10509607A (en) Device for aerosol transport of peptide drugs
ES2896001T3 (en) Aerosol Delivery Device
US20100132699A1 (en) Burst valve for aerosol device
CA3132941A1 (en) Nebulizer monitoring device, system and method cross-reference to related application
US8712794B2 (en) Methods and systems for presenting an inhalation experience
Schuster et al. The AERx pulmonary drug delivery system
US20100169259A1 (en) Methods and systems for presenting an inhalation experience

Legal Events

Date Code Title Description
AS Assignment

Owner name: SEARETE LLC,WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HYDE, RODERICK A.;ISHIKAWA, MURIEL Y.;KARE, JORDIN T.;AND OTHERS;SIGNING DATES FROM 20090611 TO 20090814;REEL/FRAME:023116/0889

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION